View Filing Data

Print Document View Excel Document

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	May 26, 2013	Jul. 19, 2013	Nov. 25, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	LANDEC CORP \CA\
Document Type	10-K
Current Fiscal Year End Date	--05-26
Entity Common Stock, Shares Outstanding		26,464,518
Entity Public Float			$ 233,854,000
Amendment Flag	false
Entity Central Index Key	0001005286
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	May 26, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	FY

Consolidated Balance Sheets - USD ($)	May 26, 2013	May 27, 2012
Current assets:
Cash and cash equivalents	$ 13,718,000	$ 22,177,000
Marketable securities	1,545,000
Accounts receivable, less allowance for doubtful accounts of $583 and $512 at May 26, 2013 and May 27, 2012, respectively	36,072,000	31,951,000
Accounts receivable, related party	671,000	323,000
Income taxes receivable	5,103,000	47,000
Inventories, net	24,113,000	22,011,000
Deferred taxes	1,582,000	2,076,000
Prepaid expenses and other current assets	2,856,000	2,578,000
Total current assets	85,660,000	81,163,000
Investment in non-public company, non-fair value	793,000	793,000
Investment in non-public company, fair value	29,600,000	21,500,000
Property and equipment, net	65,811,000	63,495,000
Goodwill, net	49,620,000	49,620,000
Trademarks/ trade names, net	48,428,000	48,428,000
Customer relationships, net	9,606,000	10,557,000
Other assets	1,424,000	2,136,000
Total Assets	290,942,000	277,692,000
Current liabilities:
Accounts payable	31,470,000	22,644,000
Related party payables	786,000	776,000
Accrued compensation	4,984,000	5,782,000
Other accrued liabilities	2,332,000	18,642,000
Deferred revenue	1,248,000	162,000
Lines of credit	4,000,000	11,666,000
Current portion of long-term debt	5,933,000	7,012,000
Total current liabilities	50,753,000	66,684,000
Long-term debt	34,372,000	40,305,000
Deferred taxes	24,054,000	18,037,000
Other non-current liabilities	1,349,000	1,108,000
Total liabilities	110,528,000	126,134,000
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.001 par value; 50,000,000 shares authorized; 26,402,247 and 25,644,580 shares issued and outstanding at May 26, 2013 and May 27, 2012, respectively	26,000	26,000
Additional paid-in capital	126,258,000	119,894,000
Retained earnings	52,409,000	29,822,000
Total stockholders’ equity	178,693,000	149,742,000
Non-controlling interest	1,721,000	1,816,000
Total Equity	180,414,000	151,558,000
Total Liabilities and Stockholders’ Equity	$ 290,942,000	$ 277,692,000

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	May 26, 2013	May 27, 2012
Allowance for doubtful accounts (in Dollars)	$ 583	$ 512
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	26,402,247	25,644,580
Common stock, shares outstanding	26,402,247	25,644,580

Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Revenues:
Product sales	$ 439,574	$ 314,414	$ 273,338
Services revenue, related party	2,134	3,138	3,391
Total revenues	441,708	317,552	276,729
Cost of revenue:
Cost of product sales	377,078	262,859	227,167
Cost of services revenue	1,870	2,555	2,867
Total cost of revenue	378,948	265,414	230,034
Gross profit	62,760	52,138	46,695
Operating costs and expenses:
Research and development	9,294	9,625	9,275
Selling, general and administrative	32,531	26,515	24,608
Other operating expenses	(3,933)	1,421	4,780
Total operating costs and expenses	37,892	37,561	38,663
Operating income	24,868	14,577	8,032
Dividend income	1,125	1,125	328
Interest income	179	180	430
Interest expense	(2,008)	(929)	(820)
Other income	8,100	5,331	472
Net income before taxes	32,264	20,284	8,442
Income tax expense	(9,452)	(7,185)	(4,181)
Consolidated net income	22,812	13,099	4,261
Non-controlling interest	(225)	(403)	(341)
Net income and comprehensive income applicable to common stockholders	$ 22,587	$ 12,696	$ 3,920
Basic net income per share (in Dollars per share)	$ 0.87	$ 0.49	$ 0.15
Diluted net income per share (in Dollars per share)	$ 0.85	$ 0.49	$ 0.15
Shares used in per share computation:
Basic (in Shares)	25,830	25,849	26,397
Diluted (in Shares)	26,626	26,126	26,626

Consolidated Statements of Changes in Stockholders' Equity (Parentheticals) - Parent [Member] - $ / shares	May 26, 2013	May 27, 2012	May 29, 2011
Minimum [Member]
Issuance of common stock net of taxes paid by Landec on behalf of employees, share price	$ 1.66	$ 2.55	$ 3.38
Maximum [Member]
Issuance of common stock net of taxes paid by Landec on behalf of employees, share price	$ 13.32	$ 6.95	$ 3.80

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	May 26, 2013	May 27, 2012	May 29, 2011
Earnout [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Earn out liability	$ (3,933,000)
Marketable Maturities [Member]
Cash flows from investing activities:
Proceeds from maturities and sale of marketable securities	3,414,000	$ 31,104,000	$ 24,843,000
Marketable Sales [Member]
Cash flows from investing activities:
Proceeds from maturities and sale of marketable securities		27,743,000	27,287,000
Consolidated net income	22,812,000	13,099,000	4,261,000
Depreciation and amortization	7,295,000	5,621,000	5,313,000
Stock-based compensation expense	1,695,000	1,872,000	1,951,000
Deferred taxes	6,511,000	3,283,000	3,257,000
Change in investment in non-public company (fair market value)	(8,100,000)	(5,838,000)	(662,000)
Increase in long-term receivable			(800,000)
Tax benefit from stock based compensation	(1,302,000)	(4,057,000)	(764,000)
Net loss on disposal of property and equipment	217,000	12,000	26,000
Long-term receivable from Monsanto			800,000
Impairment charges			4,780,000
Accounts receivable, net	(4,121,000)	(3,246,000)	(3,016,000)
Accounts receivable, related party	(348,000)	130,000	276,000
Income taxes receivable	(3,754,000)	4,581,000	878,000
Inventories, net	(2,102,000)	(441,000)	(4,054,000)
Issuance of notes and advances receivable	(4,173,000)	(3,699,000)	(3,073,000)
Collection of notes and advances receivable	4,173,000	3,704,000	3,314,000
Prepaid expenses and other current assets	(278,000)	3,588,000	602,000
Accounts payable	8,826,000	(544,000)	2,393,000
Related party accounts payable	10,000	476,000	(49,000)
Accrued compensation	(798,000)	2,701,000	1,038,000
Other accrued liabilities	(2,486,000)	3,434,000	532,000
Deferred revenue	1,086,000	(2,495,000)	(1,734,000)
Net cash provided by operating activities	21,230,000	22,181,000	14,469,000
Purchases of property and equipment	(8,877,000)	(5,371,000)	(6,684,000)
Acquisition of GreenLine (Note 2)		(66,826,000)
Purchase of marketable securities	(4,959,000)	(30,723,000)	(59,833,000)
Proceeds from maturities and sale of marketable securities	0	27,700,000
Investment in non-public company (fair market value)			(15,000,000)
Net cash used in investing activities	(10,422,000)	(44,073,000)	(29,387,000)
Cash flows from financing activities:
Repurchase of outstanding common stock		(5,006,000)	(1,184,000)
Proceeds from sale of common stock	3,416,000	61,000	126,000
Taxes paid by Company for stock swaps and RSUs	(49,000)	(260,000)	(218,000)
Tax benefit from stock-based compensation expense	1,302,000	4,057,000	764,000
Earn out payment from Lifecore acquisition	(9,650,000)
Net change in other assets/liabilities	712,000	(1,813,000)	49,000
Proceeds from long term debt		31,816,000
Proceeds from lines of credit		12,766,000
Payments on long term debt	(7,012,000)	(4,329,000)	(3,940,000)
Payments on lines of credit	(7,666,000)	(1,100,000)
Payments to non-controlling interest.	(320,000)	(258,000)	(361,000)
Net cash provided by (used in) financing activities	(19,267,000)	35,934,000	(4,764,000)
Net increase (decrease) in cash and cash equivalents	(8,459,000)	14,042,000	(19,682,000)
Cash and cash equivalents at beginning of year	22,177,000	8,135,000	27,817,000
Cash and cash equivalents at end of year	13,718,000	22,177,000	8,135,000
Supplemental disclosure of cash flows information:
Cash paid during the period for interest	1,728,000	952,000	761,000
Cash paid during the period for income taxes	$ 5,605,000	$ 246,000	$ 146,000

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies

12 Months Ended

May 26, 2013

Accounting Policies [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

1. Organization, Basis of Presentation, and Summary of Significant Accounting Policies

Organization

Landec Corporation and its subsidiaries (“Landec” or the “Company”) design, develop, manufacture and sell differentiated products for food and biomaterials markets and license technology applications to partners. The Company has two proprietary polymer technology platforms: 1) Intelimer® polymers, and 2) hyaluronan (“HA”) biopolymers. The Company’s HA biopolymers are proprietary in that they are specially formulated for specific customers to meet strict regulatory requirements. The Company’s polymer technologies, along with its customer relationships and trade names, are the foundation, and a key differentiating advantage upon which Landec has built its business. The Company sells specialty packaged branded Eat Smart and GreenLine and private label fresh-cut vegetables and whole produce to retailers, club stores and foodservice operators, primarily in the United States, Canada and Asia through its Apio, Inc. (“Apio”) subsidiary and sells HA-based biomaterials through its Lifecore Biomedical, Inc. (“Lifecore”) subsidiary.

Basis of Presentation

Basis of Consolidation

The consolidated financial statements are presented on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles and include the accounts of Landec Corporation and its subsidiaries, Apio and Lifecore. All material inter-company transactions and balances have been eliminated.

Arrangements that are not controlled through voting or similar rights are reviewed under the guidance for variable interest entities (“VIEs”). A company is required to consolidate the assets, liabilities and operations of a VIE if it is determined to be the primary beneficiary of the VIE.

An entity is a VIE and subject to consolidation, if by design: a) the total equity investment at risk is not sufficient to permit the entity to finance its activities without additional subordinated financial support provided by any parties, including equity holders or b) as a group the holders of the equity investment at risk lack any one of the following three characteristics: (i) the power, through voting rights or similar rights to direct the activities of an entity that most significantly impact the entity’s economic performance, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity. The Company reviewed the consolidation guidance and concluded that the partnership interest and equity investment in non-public companies by the Company are not VIEs.

Reclassifications

Certain reclassifications have been made to prior year financial statements to conform to the current year presentation.

Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; sales returns and allowances; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets; the valuation of intangible assets and inventory; the valuation of investments; and the valuation and recognition of stock-based compensation.

These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and are subject to change from period to period. The actual results may differ from management’s estimates.

Concentrations of Risk

Cash and cash equivalents, marketable securities, trade accounts receivable, grower advances and notes receivable are financial instruments that potentially subject the Company to concentrations of credit risk. Our Company policy limits, among other things, the amount of credit exposure to any one issuer and to any one type of investment, other than securities issued or guaranteed by the U.S. government. The Company routinely assesses the financial strength of customers and growers and, as a consequence, believes that trade receivables, grower advances and notes receivable credit risk exposure is limited. Credit losses for bad debt are provided for in the consolidated financial statements through a charge to operations. A valuation allowance is provided for known and anticipated credit losses. The recorded amounts for these financial instruments approximate their fair value.

Several of the raw materials we use to manufacture our products are currently purchased from a single source, including some monomers used to synthesize Intelimer polymers, substrate materials for our breathable membrane products and raw materials for our HA products.

The operations of Windset, in which the Company holds a 20.1% minority investment, are predominantly located in British Columbia and Santa Maria, California. Routinely, the Company evaluates the financial strength and ability for Windset to continue as a going concern.

During the fiscal year ended May 26, 2013, sales to the Company’s top five customers accounted for approximately 40% of total revenue with the top two customers from the Food Products Technology segment accounting for approximately 16% and 13%, respectively, of total revenues. In addition, approximately 30% of the Company’s total revenues were derived from product sales to international customers, none of which individually accounted for more than 5% of total revenues. As of May 26, 2013, the top two customers from the Food Products Technology segment both represented approximately 15% of total accounts receivable.

During the fiscal year ended May 27, 2012, sales to the Company’s top five customers accounted for approximately 45% of total revenue with the top two customers from the Food Products Technology segment accounting for approximately 17% and 11%, respectively, of total revenues. In addition, approximately 36% of the Company’s total revenues were derived from product sales to international customers, one of whom individually accounted for more than 5% of total revenues. As of May 27, 2012, the top two customers from the Food Products Technology segment both represented approximately 11% of total accounts receivable.

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. Recoverability of assets is measured by comparison of the carrying amount of the asset to the net undiscounted future cash flow expected to be generated from the asset. If the future undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets’ carrying value is adjusted to fair value. The Company regularly evaluates its long-lived assets for indicators of possible impairment.

Financial Instruments

The Company’s financial instruments are primarily composed of marketable securities, commercial-term trade payables, grower advances, notes receivable and debt instruments. For short-term instruments, the historical carrying amount approximates the fair value of the instrument. The fair value of long-term debt and lines of credit approximates their carrying value. Fair values for long-term financial instruments not readily marketable are estimated based upon discounted future cash flows at prevailing market interest rates. Based on these assumptions, management believes the fair market values of the Company’s financial instruments are not significantly different from their recorded amounts as of May 26, 2013 and May 27, 2012.

Accounts Receivable and Allowance for Doubtful Accounts

The Company carries its accounts receivable at their face amounts less an allowance for doubtful accounts. On a periodic basis, the Company evaluates its accounts receivable and establishes an allowance for doubtful accounts and estimated losses resulting from the inability of its customers to make required payments. The allowance for doubtful accounts is determined based on review of the overall condition of accounts receivable balances and review of significant past due accounts. The allowance for doubtful accounts is based on specific identification of past due amounts and for accounts over 90-days past due. The changes in the Company’s allowance for doubtful accounts are summarized in the following table (in thousands).

	Balance at beginning of period		Additions from acquisitions and additions from charges to costs and expenses		Write offs net of recoveries			Balance at end of period
Year ended May 29, 2011	$	189	$	209	$	(56	)	$	342

Year ended May 27, 2012	$	342	$	248	$	(78	)	$	512

Year ended May 26, 2013	$	512	$	109	$	(38	)	$	583

Revenue Recognition

Revenue from product sales is recognized when there is persuasive evidence that an arrangement exists, title has transferred, the price is fixed or determinable, and collectability is reasonably assured. Allowances are established for estimated uncollectible amounts, product returns, and discounts based on specific identification and historical losses.

The Company takes title to all produce it trades and/or packages, and therefore, records revenues and cost of sales at gross amounts in the Consolidated Statements of Comprehensive Income. Revenue recognition for product sales generally occurs when the customer receives the product or at the time title passes to the customer. Customers generally do not have the right to return product unless damaged or defective. Net sales is comprised of gross sales reduced by customer returns and consumer promotion allowances.

Licensing revenue is recognized in accordance with accounting guidance. Initial license fees are deferred and amortized to revenue over the period of the agreement when a contract exists, the fee is fixed and determinable, and collectability is reasonably assured. Noncancellable, nonrefundable license fees are recognized over the period of the agreement, including those governing research and development activities and any related supply agreement entered into concurrently with the license when the risk associated with commercialization of a product is non-substantive at the outset of the arrangement.

Contract revenue for research and development (R&D) is recorded as earned, based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and there is no continuing involvement by the Company, are recognized on the earlier of when the payments are received or when collection is assured.

When a sales arrangement contains multiple elements, the Company allocates revenue to each element based on a selling price hierarchy. The relative selling price for a deliverable is based on its vendor-specific objective evidence (VSOE), if available, third-party evidence (TPE), if VSOE is not available, or estimated selling price, if neither VSOE nor TPE is available. The Company then recognizes revenue on each deliverable in accordance with its policies for product and service revenue recognition. The Company is not typically able to determine VSOE or TPE, and therefore, uses estimated selling prices to allocate revenue between the elements of the arrangement.

The Company limits the amount of revenue recognition for delivered elements to the amount that is not contingent on the future delivery of products or services or future performance obligations or subject to customer-specific cancellation rights. The Company evaluates each deliverable in an arrangement to determine whether they represent separate units of accounting. A deliverable constitutes a separate unit of accounting when it has stand-alone value, and for an arrangement that includes a general right of return relative to the delivered products or services, delivery or performance of the undelivered product or service is considered probable and is substantially controlled by the Company. The Company considers a deliverable to have stand-alone value if the product or service is sold separately by the Company or another vendor or could be resold by the customer. Further, the revenue arrangements generally do not include a general right of return relative to the delivered products. Where the aforementioned criteria for a separate unit of accounting are not met, the deliverable is combined with the undelivered element(s) and treated as a single unit of accounting for the purposes of allocation of the arrangement consideration and revenue recognition. The Company allocates the total arrangement consideration to each separable element of an arrangement based upon the relative selling price of each element. Allocation of the consideration is determined at arrangement inception on the basis of each unit’s relative selling price. In instances where the Company has not established fair value for any undelivered element, revenue for all elements is deferred until delivery of the final element is completed and all recognition criteria are met.

Shipping and Handling Costs

Amounts billed to third-party customers for shipping and handling are included as a component of revenues. Shipping and handling costs incurred are included as a component of cost of products sold and represent costs incurred to ship product from the sourcing locations to the end consumer markets.

Other Accounting Policies and Disclosures

Cash and Cash Equivalents

The Company records all highly liquid securities with three months or less from date of purchase to maturity as cash equivalents. Cash equivalents consist mainly of certificate of deposits (CDs), money market funds and U.S. Treasuries. The market value of cash equivalents approximates their historical cost given their short-term nature.

Marketable Securities

Short-term marketable securities consist of CDs that are FDIC insured and single A or better rated corporate and municipal bonds with original maturities of more than three months at the date of purchase regardless of the maturity date. The Company classifies all debt securities with readily determinable market values as “available for sale” as the Company views the funds within its portfolio as available for use in its current operations. The aggregate amount of CDs included in marketable securities as of May 26, 2013 and May 27, 2012 was $701,000 and zero, respectively. The contractual maturities of the Company's marketable securities that are due in less than one year represent $1.3 million and zero of its marketable securities and those due in one to two years represent the remaining $251,000 and zero of the Company’s marketable securities as of May 26, 2013 and May 27, 2012, respectively. Investments in marketable securities are carried at fair market value with unrealized gains and losses reported as other income. The cost of debt securities is adjusted for amortization of premiums and discounts to maturity. This amortization is recorded to interest income. Realized gains and losses on the sale of available for sale securities are also recorded to interest income and were not significant for the fiscal years ended May 26, 2013 and May 27, 2012. During fiscal years 2013 and 2012, the Company received proceeds of zero and $27.7 million, respectively, from the sale of marketable securities. The cost of securities sold is based on the specific identification method.

Inventories

Inventories are stated at the lower of cost (using the first-in, first-out method) or market. As of May 26, 2013 and May 27, 2012 inventories consisted of (in thousands):

	May 26, 2013		May 27, 2012
Finished goods	$	11,297	$	9,406
Raw materials		9,290		9,876
Work in progress		3,526		2,729
Inventories, net	$	24,113	$	22,011

If the cost of the inventories exceeds their net realizable value, provisions are recorded currently to reduce them to net realizable value. The Company also provides a provision for slow moving and obsolete inventories.

Advertising Expense

Advertising expenditures for the Company are expensed as incurred. Advertising expense for the Company for fiscal years 2013, 2012 and 2011 was $445,000, $406,000 and $458,000, respectively.

Notes and Advances Receivable

Apio issues notes and makes advances to produce growers for their crop and harvesting costs primarily for the purpose of sourcing crops for Apio's business. Notes receivable and advances are generally recovered during the growing season (less than one year) using proceeds from the crops sold to Apio. Notes are interest bearing obligations, evidenced by contracts and notes receivable. These notes and advances receivable are secured by perfected liens on crops, have terms that range from three to nine months, and are reviewed at least quarterly for collectability. A reserve is established for any note or advance deemed to not be fully collectible based upon an estimate of the crop value or the fair value of the security for the note or advance. There were no notes or advances outstanding at May 26, 2013.

Related Party Transactions

The Company provides cooling and distribution services to both a farm and Beachside Produce LLC ("Beachside"), a commodity produce distributor, in which the Chairman of Apio has a farming and ownership interest, respectively. During fiscal years 2013, 2012 and 2011, the Company recognized revenues of $2.5 million, $3.8 million, and $4.1 million, respectively, which have been included in product sales and in service revenues in the accompanying Consolidated Statements of Comprehensive Income, from the sale of products and providing cooling services to these parties. The related receivable balances of $671,000 and $323,000 are included in accounts receivable in the accompanying Consolidated Balance Sheets as of May 26, 2013 and May 27, 2012, respectively.

Additionally, unrelated to the revenue transactions above, the Company purchases produce from Beachside, a farm in which the Chairman of Apio has an ownership interest, and Windset Holding 2010 Ltd., a Canadian corporation (“Windset”) for sale to third parties. During fiscal years 2013, 2012 and 2011, the Company recognized cost of product sales of $6.7 million, $5.6 million and $3.6 million, respectively, in the accompanying Consolidated Statements of Comprehensive Income, from the sale of products purchased from these parties. The related accounts payable of $786,000 and $776,000 are included in related party accounts payable in the accompanying Consolidated Balance Sheets as of May 26, 2013 and May 27, 2012, respectively.

All related party transactions are monitored quarterly by the Company and approved by the Audit Committee of the Board of Directors.

Property and Equipment

Property and equipment are stated at cost. Expenditures for major improvements are capitalized while repairs and maintenance are charged to expense. Depreciation is expensed on a straight-line basis over the estimated useful lives of the respective assets, generally three to thirty years for buildings and leasehold improvements and three to seven years for furniture and fixtures, computers, capitalized software, capitalized leases, machinery, equipment and autos. Leasehold improvements are amortized on a straight-line basis over the lesser of the economic life of the improvement or the life of the lease.

The Company capitalizes software development costs for internal use in accordance with accounting guidance. Capitalization of software development costs begins in the application development stage and ends when the asset is placed into service. The Company amortizes such costs using the straight-line basis over estimated useful lives of three to seven years. During fiscal years 2013 and 2012, the Company did not capitalize any software development costs.

Long-Lived Assets

The Company’s Long-Lived Assets consist of property, plant and equipment, and intangible assets. Intangible assets are comprised of customer relationships with an estimated useful life of twelve to thirteen years (the “finite-lived intangible assets”) and trademarks/trade names and goodwill with indefinite lives (collectively, “the indefinite-lived intangible assets”), which the Company recognized in accordance with accounting guidance (i) upon the acquisition of GreenLine Holding Company (“GreenLine”) by Apio in April 2012, (ii) upon the acquisition of Lifecore in April 2010 and (iii) upon the acquisition of Apio in December 1999. Accounting guidance defines goodwill as “the excess of the cost of an acquired entity over the net of the estimated fair values of the assets acquired and the liabilities assumed at date of acquisition.” All intangible assets, including goodwill, associated with the acquisition of Lifecore was allocated to our HA-based Biomaterials reporting unit and the acquisitions of Apio and GreenLine were allocated to our Food Products Technology reporting unit pursuant to accounting guidance based upon the allocation of assets and liabilities acquired and consideration paid for each reporting unit. As of May 26, 2013, the HA-based Biomaterials reporting unit had $13.9 million of goodwill and the Food Products Technology reporting unit had $35.7 million of goodwill.

Property, plant and equipment and finite-lived intangible assets are reviewed for possible impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset (or asset group) may not be recoverable. The Company’s impairment review requires significant management judgment including estimating the future success of product lines, future sales volumes, revenue and expense growth rates, alternative uses for the assets and estimated proceeds from the disposal of the assets. The Company conducts quarterly reviews of idle and underutilized equipment, and reviews business plans for possible impairment indicators. Impairment is indicated when the carrying amount of the asset (or asset group) exceeds its estimated future undiscounted cash flows and the impairment is viewed as other than temporary. When impairment is indicated, an impairment charge is recorded for the difference between the asset’s book value and its estimated fair value. Depending on the asset, estimated fair value may be determined either by use of a discounted cash flow model or by reference to estimated selling values of assets in similar condition. The use of different assumptions would increase or decrease the estimated fair value of assets and would increase or decrease any impairment measurement.

The Company tests its indefinite-lived intangible assets for impairment at least annually, in accordance with accounting guidance. For non-goodwill indefinite-lived intangible assets, the Company performs a qualitative analysis in accordance with ASC 350-30-35. For goodwill, the Company performs a quantitative analysis in accordance with ASC 350-20-35.

Application of the impairment tests for indefinite-lived intangible assets requires significant judgment by management, including identification of reporting units, assignment of assets and liabilities to reporting units, assignment of intangible assets to reporting units, and the determination of the fair value of each indefinite-lived intangible asset and reporting unit based upon projections of future net cash flows, discount rates and market multiples, which judgments and projections are inherently uncertain.

The Company tested its indefinite-lived intangible assets for impairment as of July 21, 2013 and determined that no adjustments to the carrying values of these assets were necessary as of that date. On a quarterly basis, the Company considers the need to update its most recent annual tests for possible impairment of its indefinite-lived intangible assets, based on management’s assessment of changes in its business and other economic factors since the most recent annual evaluation. Such changes, if significant or material, could indicate a need to update the most recent annual tests for impairment of the indefinite-lived intangible assets during the current period. The results of these tests could lead to write-downs of the carrying values of these assets in the current period.

The Company uses the discounted cash flow (“DCF”) approach to develop an estimate of fair value for goodwill. The DCF approach recognizes that current value is premised on the expected receipt of future economic benefits. Indications of value are developed by discounting projected future net cash flows to their present value at a rate that reflects both the current return requirements of the market and the risks inherent in the specific investment. The market approach is not used to value the Company’s reporting units (the “reporting units”) because insufficient market comparables exist to enable the Company to develop a reasonable fair value of its intangible assets due to the unique nature of each of the Company’s reporting units.

The DCF approach requires the Company to exercise judgment in determining future business and financial forecasts and the related estimates of future net cash flows. Future net cash flows depend primarily on future product sales, which are inherently difficult to predict. These net cash flows are discounted at a rate that reflects both the current return requirements of the market and the risks inherent in the specific investment.

The DCF associated with the annual goodwill impairment analysis for the Food Products Technology reporting unit is based on management’s five-year projection of revenues, gross profits and operating profits by fiscal year and assumes a 37% effective tax rate for each year. Management takes into account the historical trends of the Food Products Technology reporting unit and the industry categories in which it operates along with inflationary factors, current economic conditions, new product introductions, cost of sales, operating expenses, capital requirements and other relevant data when developing its projection. The estimated fair value of the Food Products Technology reporting unit as of July 21, 2013 was 111% of its book value at that date, therefore, no goodwill impairment was deemed to exist. For the test performed as of July 22, 2012, the projected cash flow from operations for determining the DCF for fiscal year 2013 was $10.2 million for the Food Products Technology reporting unit. The actual cash flow from operations for fiscal year 2013 was $13.6 million. The difference of $3.4 million was primarily due to the timing of working capital changes.

The DCF associated with the annual goodwill impairment analysis for the HA-based Biomaterials reporting unit is based on management’s five-year projections of revenues, gross profits and operating profits by fiscal year and assumes a 37% effective tax rate for each year. Management takes into account the historical trends of HA-based Biomaterials reporting unit and the industry categories in which it operates along with inflationary factors, current economic conditions, new product introductions, cost of sales, operating expenses, capital requirements and other relevant data when developing its projection. The trade name intangible asset was valued using the relief from royalty valuation method and the customer relationship intangible asset was valued using the multi-period excess earnings method. The fair value of goodwill was calculated as the excess of consideration paid, including the fair value of contingent consideration under the terms of the purchase agreement, over the fair value of the tangible and intangible assets acquired less liabilities assumed. The Company updated its analysis of the fair value of the indefinite-lived intangible assets as of its annual impairment analysis date, concluding that the fair value of the HA-based Biomaterials reporting unit, as determined by the DCF approach, was 117% of its book value at that date, therefore, no goodwill impairment was deemed to exist. For the test performed as of July 22, 2012, the projected cash flow from operations for determining the DCF for fiscal year 2013 was a $8.4 million for the HA-based Biomaterials reporting unit. The actual cash flow from operations for fiscal year 2013 was $13.2 million. The difference of $4.8 million is primarily due to timing of working capital changes.

Investment in Non-Public Company

The Company’s investment in Aesthetic Science is carried at cost and adjusted for impairment losses. Since there is no readily available market value information, the Company periodically reviews this investment to determine if an other than temporary decline in value has occurred based on the financial stability and viability of Aesthetic Science.

Aesthetic Science sold the rights to its Smartfil™ Injector System on July 16, 2010. As a result, Landec evaluated its cost method investment for impairment, utilizing a discounted cash flow analysis. Based on the terms of the agreement, the Company determined that its investment was other than temporarily impaired and therefore, recorded an impairment loss of $1.0 million in fiscal year 2010. The Company’s carrying value of its investment in Aesthetic Sciences, net of the impairment loss, is $793,000 at May 26, 2013 and May 27, 2012.

On February 15, 2011, the Company made an investment in Windset which is reported as an investment in non-public company, fair value, in the accompanying Consolidated Balance Sheets as of May 26, 2013 and May 27, 2012. The Company has elected to account for its investment in Windset under the fair value option (see Note 4).

Deferred Revenue

Cash received in advance of services performed (principally related to upfront license fees) are recorded as deferred revenue. At May 26, 2013, $1.2 million was recognized as advances from customers. At May 27, 2012, $162,000 was recognized as advances from customers.

Non-Controlling Interest

The Company reports all non-controlling interests as a separate component of stockholders’ equity. The non-controlling interest’s share of the income or loss of the consolidated subsidiary is reported as a separate line item in our Consolidated Statements of Comprehensive Income, following the consolidated net income caption.

In connection with the acquisition of Apio, Landec acquired Apio’s 60% general partner interest in Apio Cooling, a California limited partnership. Apio Cooling is included in the consolidated financial statements of Landec for all periods presented. The non-controlling interest balance of $1.7 million at May 26, 2013 and $1.8 million at May 27, 2012 is comprised of the non-controlling limited partners’ interest in Apio Cooling.

Income Taxes

The Company accounts for income taxes in accordance with accounting guidance which requires that deferred tax assets and liabilities be recognized using enacted tax rates for the effect of temporary differences between the book and tax basis of recorded assets and liabilities. The Company maintains valuation allowances when it is likely that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances from period to period are included in the Company’s income tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company takes into account such factors as prior earnings history, expected future earnings, unsettled circumstances that, if unfavorably resolved, would adversely affect utilization of a deferred tax asset, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of realization of a deferred tax asset. At May 26, 2013, the Company had $783,000 valuation allowance against deferred tax assets.

In addition to valuation allowances, the Company establishes accruals for uncertain tax positions. The tax-contingency accruals are adjusted in light of changing facts and circumstances, such as the progress of tax audits, case law and emerging legislation. The Company recognizes interest and penalties related to uncertain tax positions as a component of income tax expense. The Company’s effective tax rate includes the impact of tax-contingency accruals as considered appropriate by management.

1. Organization, Basis of Presentation, and Summary of Significant Accounting Policies (continued)

A number of years may elapse before a particular matter, for which the Company has accrued, is audited and finally resolved. The number of years with open tax audits varies by jurisdiction. While it is often difficult to predict the final outcome or the timing of resolution of any particular tax matter, the Company believes its tax-contingency accruals are adequate to address known tax contingencies. Favorable resolution of such matters could be recognized as a reduction to the Company’s effective tax rate in the year of resolution. Unfavorable settlement of any particular issue could increase the effective tax rate. Any resolution of a tax issue may require the use of cash in the year of resolution. The Company’s tax-contingency accruals are recorded in other accrued liabilities in the accompanying Consolidated Balance Sheets.

Per Share Information

Accounting guidance requires the presentation of basic and diluted earnings per share. Basic earnings per share excludes any dilutive effects of options, warrants and convertible securities and is computed using the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution as if securities or other contracts to issue common stock were exercised or converted into common stock. Diluted common equivalent shares consist of stock options and restricted stock units, calculated using the treasury stock method.

The following table sets forth the computation of diluted net income per share (in thousands, except per share amounts):

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Numerator:
Net income applicable to Common Stockholders	$	22,587	$	12,696	$	3,920
Denominator:
Weighted average shares for basic net income per share		25,830		25,849		26,397
Effect of dilutive securities:
Stock options and restricted stock units		796		277		229
Weighted average shares for diluted net income per share		26,626		26,126		26,626

Diluted net income per share	$	0.85	$	0.49	$	0.15

Options to purchase 88,022, 1,855,167 and 2,032,867 shares of Common Stock at a weighted average exercise price of $12.80, $6.72 and $6.67 per share were outstanding during fiscal years ended May 26, 2013, May 27, 2012 and May 29, 2011, respectively, but were not included in the computation of diluted net income per share because the options’ exercise price were greater than the average market price of the Common Stock and, therefore, their inclusion would be antidilutive.

Cost of Sales

The Company includes in cost of sales all the costs related to the sale of products in accordance with generally accepted accounting principles. These costs include the following: raw materials (including produce, seeds, packaging, syringes and fermentation and purification supplies), direct labor, overhead (including indirect labor, depreciation, and facility related costs) and shipping and shipping related costs.

Research and Development Expenses

Costs related to both research and development contracts and Company-funded research is included in research and development expenses. Research and development costs are primarily comprised of salaries and related benefits, supplies, travel expenses, consulting expenses and corporate allocations.

Accounting for Stock-Based Compensation

The Company records compensation expense for stock-based awards issued to employees and directors in exchange for services provided based on the estimated fair value of the awards on their grant dates and is recognized over the required service periods. The cash flows resulting from the tax benefit due to tax deductions in excess of the compensation expense recognized for those options (excess tax benefit) are classified as financing activities with the statement of cash flows. The Company’s stock-based awards include stock option grants and restricted stock unit awards (RSUs).

During the fiscal year ended May 26, 2013, the Company recognized stock-based compensation expense of $1,695,000 which included $907,000 for restricted stock unit awards and $788,000 for stock option grants. During the fiscal year ended May 27, 2012, the Company recognized stock-based compensation expense of $1,872,000 which included $826,000 for restricted stock unit awards and $1,046,000 for stock option grants. During the fiscal year ended May 29, 2011, the Company recognized stock-based compensation expense of $1,951,000 which included $857,000 for restricted stock unit awards and $1,094,000 for stock option grants.

The following table summarizes the stock-based compensation by income statement line item:

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Research and development	$	718,000	$	530,000	$	565,000
Sales, general and administrative		977,000		1,342,000		1,386,000
Total stock-based compensation expense	$	1,695,000	$	1,872,000	$	1,951,000

The estimated fair value for stock options, which determines the Company’s calculation of compensation expense, is based on the Black-Scholes option pricing model. The Company uses the straight line single option method to calculate and recognize the fair value of stock-based compensation arrangements. In addition, the Company uses historical data to estimate pre-vesting forfeitures and records stock-based compensation expense only for those awards that are expected to vest and revises those estimates in subsequent periods if the actual forfeitures differ from the prior estimates.

The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility. As of May 26, 2013, May 27, 2012 and May 29, 2011, the fair value of stock option grants was estimated using the following weighted average assumptions:

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Expected life (in years)		3.76		3.76		3.76
Risk-free interest rate		0.48%		0.59%		1.16%
Volatility		0.53		0.53		0.52
Dividend yield		0%		0%		0%

The weighted average estimated fair value of Landec employee stock options granted at grant date market prices during the fiscal years ended May 26, 2013, May 27, 2012 and May 29, 2011 was $3.57, $2.65 and $2.42 per share, respectively. No stock options were granted above or below grant date market prices during the fiscal years ended May 26, 2013, May 27, 2012 and May 29, 2011.

Fair Value Measurements

The Company uses fair value measurement accounting for financial assets and liabilities and for financial instruments and certain other items measured at fair value. The Company has elected the fair value option for its investment in a non-public company (see Note 4). The Company has not elected the fair value option for any of its other eligible financial assets or liabilities.

The accounting guidance established a three-tier hierarchy for fair value measurements, which prioritizes the inputs used in measuring fair value as follows:

Level 1 – observable inputs such as quoted prices for identical instruments in active markets.

Level 2 – inputs other than quoted prices in active markets that are observable either directly or indirectly through corroboration with observable market data.

Level 3 – unobservable inputs in which there is little or no market data, which would require the Company to develop its own assumptions.

As of May 26, 2013, the Company held certain assets and liabilities that are required to be measured at fair value on a recurring basis, including marketable securities, interest rate swap and its minority interest investment in Windset.

The fair value of the Company’s marketable securities is determined based on observable inputs that are readily available in public markets or can be derived from information available in publicly quoted markets. Therefore, the Company has categorized its marketable securities as a Level 1 measurement.

The fair value of the Company’s interest rate swap is determined based on model inputs that can be observed in a liquid market, including yield curves, and is categorized as a Level 2 measurement.

The fair value of the Company’s liability for contingent consideration as of May 27, 2012 was based on significant inputs not observed in the market and thus represented a Level 3 measurement. The Company determined the fair value of the liability for the contingent consideration as of May 27, 2012, based on a probability-weighted discounted cash flow analysis.

The Company has elected the fair value option of accounting for its investment in Windset. The calculation of fair value utilizes significant unobservable inputs in the discounted cash flow models, including projected cash flows, growth rates and discount rates. As a result, the Company’s investment in Windset is considered to be a Level 3 measurement investment. The change in the fair market value of the Company’s investment in Windset for the fiscal years ended May 26, 2013 and May 27, 2012 was due to the Company’s 20.1% minority interest in the change in the fair market value of Windset during those periods. In determining the fair value of the investment in Windset, the Company utilizes the following significant unobservable inputs in the discounted cash flow models:

	At May 26, 2013			At May 27, 2012
Revenue growth rates	3%	to	9%	3%	to	24%
Expense growth rates	3%	to	8%	3%	to	18%
Income tax rates		15%			25%
Discount rates	18%	to	28%	14%	to	21%

The revenue growth, expense growth and income tax rate assumptions, consider the Company's best estimate of the trends in those items over the discount period. The discount rate assumption takes into account the risk-free rate of return, the market equity risk premium and the company’s specific risk premium and then applies an additional discount for lack of liquidity of the underlying securities. The discounted cash flow valuation model used by the Company has the following sensitivity to changes in inputs and assumptions (in thousands):

	Impact on value of Windset investment as of May 26, 2013
10% increase in revenue growth rates	$1,700
10% increase in expense growth rates	($1,400)
10% increase in income tax rates	($100)
10% increase in discount rates	($900)

Imprecision in estimating unobservable market inputs can affect the amount of gain or loss recorded for a particular position. The use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

The following table summarizes the fair value of the Company’s assets and liabilities that are measured at fair value on a recurring basis, as of May 26, 2013 and May 27, 2012 (in thousands):

	Fair Value at May 26, 2013						Fair Value at May 27, 2012
	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3
Assets:
Marketable securities	$	1,545	$	-	$	-	$	-	$	-	$	-
Investment in private company		-		-		29,600		-		-		21,500
Total	$	1,545	$	-	$	29,600	$	-	$	-	$	21,500

Liabilities:
Contingent consideration	$	-	$	-	$	-	$	-	$	-	$	3,933
Interest rate swap		-		163		-		-		347		-
Total	$	-	$	163	$	-	$	-	$	347	$	3,933

Recent Accounting Pronouncements

Intangibles-Goodwill and Other

In September 2011, the FASB issued new guidance that will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill and intangibles impairment test. Under this amendment, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendment includes a number of events and circumstances for an entity to consider in conducting the qualitative assessment. The guidance is effective for fiscal years beginning after December 15, 2011 with early adoption permitted. The Company adopted this standard beginning in fiscal year 2013 and the adoption did not have a material impact on the Company’s consolidated financial statements.

Presentation of Comprehensive Income

In December 2011, the FASB issued new guidance that improves the comparability, consistency, and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity. The amendments in this standard require that all non-owner changes in stockholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income ("OCI") to net income, in both net income and OCI. The standard does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, the standard does not affect the calculation or reporting of earnings per share. For public entities, the amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and are to be applied retrospectively, with early adoption permitted. The Company retrospectively adopted this standard beginning in fiscal year 2013.

Fair Value Measurement

In May 2011, the FASB issued new guidance effective for annual reporting periods beginning after December 15, 2011. This guidance amends certain accounting and disclosure requirements related to fair value measurements. Additional disclosure requirements in the update include: (1) for Level 3 fair value measurements, quantitative information about unobservable inputs used, a description of the valuation processes used by the entity, and a qualitative discussion about the sensitivity of the measurements to changes in the unobservable inputs; (2) for an entity’s use of a nonfinancial asset that is different from the asset’s highest and best use, the reason for the difference; (3) for financial instruments not measured at fair value but for which disclosure of fair value is required, the fair value hierarchy level in which the fair value measurements were determined; and (4) the disclosure of all transfers between Level 1 and Level 2 of the fair value hierarchy. The Company adopted this standard beginning in fiscal year 2013.

Disclosures about Offsetting Assets and Liabilities

In November 2011, the FASB issued new guidance effective for annual reporting periods beginning January 1, 2013. This guidance amends the disclosure requirements around offsetting to enable users of the financial statements to understand the effect of those arrangements on its financial position. Entities are required to disclose both gross and net information about the instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements.

- Definition

The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.

+ References + Details

Note 2 - Acquisitions

12 Months Ended

May 26, 2013

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]

2. Acquisitions

GreenLine Holding Company

On April 23, 2012 (the “GreenLine Acquisition Date”), Apio acquired all of the outstanding equity of GreenLine under a Stock Purchase Agreement (the “GreenLine Purchase Agreement”) in order to expand its product offerings and enter into new markets such as foodservice. GreenLine, headquartered in Bowling Green, Ohio, was a privately-held company and is the leading processor and marketer of value-added, fresh-cut green beans in North America. GreenLine has four processing and distribution plants one each in Ohio, Pennsylvania, Florida and California and distribution centers in New York and South Carolina.

Under the GreenLine Purchase Agreement, the aggregate consideration paid at closing consisted of $62.9 million in cash, including $4.7 million that is held in an escrow account to secure Landec’s indemnification rights with respect to certain matters, including breaches of representations, warranties and covenants. In addition, the GreenLine Purchase Agreement included a potential earn out payment up to $7.0 million in the event that GreenLine achieved certain revenue targets during calendar year 2012. The earn out was comprised of $4.0 million for achieving a certain revenue target during calendar year 2012, and up to an additional $3.0 million for exceeding the revenue target by $3.0 million or more. In April 2012, the Company performed an analysis of projected revenues for GreenLine and concluded at that time that it was probable that GreenLine would meet, but not exceed, the initial revenue target and therefore, the Company recorded a $3.9 million liability as of May 27, 2012, representing the present value of the expected earn out payment. As a result of the severe drought in the Midwest during 2012, lower than expected results from new product launches and new planned business not being realized, during the second quarter of fiscal year 2013, the Company determined that GreenLine did not achieve the earn out revenue target. As a result, the Company reversed the $3.9 million liability recorded for the earn out and recorded a corresponding credit to other operating expenses in its Consolidated Statements of Comprehensive Income for fiscal year 2013.

The operating results of GreenLine are included in the Company’s financial statements beginning April 23, 2012, in the Food Products Technology operating segment. Included in the Company’s results for the fiscal year 2012 was $9.1 million of GreenLine’s net sales.

The acquisition date fair value of the total consideration transferred was $66.8 million, which consisted of the following (in thousands):

Cash	$	62,900
Contingent consideration		3,933
Total	$	66,833

The assets and liabilities of GreenLine were recorded at their respective estimated fair values as of the date of the acquisition using generally accepted accounting principles for business combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to goodwill. Goodwill represents a substantial portion of the acquisition proceeds because of the workforce in-place at acquisition and because of GreenLine’s long history and future prospects. Management believes that there is further growth potential by extending GreenLine’s product lines into new channels, such as club stores.

The following table summarizes the estimated fair values of GreenLine’s assets acquired and liabilities assumed and related deferred income taxes, effective April 23, 2012, the date the Company obtained control of GreenLine (in thousands).

Accounts receivable, net	$	7,057
Inventories, net		1,409
Property and equipment		11,669
Other tangible assets		306
Intangible assets		43,500
Total identifiable assets acquired		63,941
Accounts payable and other liabilities		(8,391	)
Deferred taxes		(1,875	)
Total liabilities assumed		(10,266	)
Net identifiable assets acquired		53,675
Goodwill		13,158
Net assets acquired	$	66,833

The Company used a combination of the market and cost approaches to estimate the fair values of the GreenLine assets acquired and liabilities assumed. During the measurement period (which is not to exceed one year from the acquisition date), the Company is required to retrospectively adjust the provisional assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets or liabilities as of that date. No adjustments were made to the fair values of GreenLine assets acquired or liabilities assumed during fiscal year 2013. The Company has finalized the fair values of the acquired assets and assumed liabilities and closed the measurement period.

Intangible Assets

The fair value of indefinite and finite-lived intangible assets was determined using a DCF model, under an income valuation methodology, based on management’s five-year projections of revenues, gross profits and operating profits by fiscal year and assumed a 40% effective tax rate for each year. Management took into account the historical trends of GreenLine and the industry categories in which GreenLine operates along with inflationary factors, current economic conditions, new product introductions, cost of sales, operating expenses, capital requirements and other relevant data when developing its projection. The Company believes that the level and timing of cash flows appropriately reflect market participant assumptions. The projected cash flows from these intangibles were based on key assumptions such as estimates of revenues and operating profits related to the intangibles over their respective forecast periods. The resultant cash flows were then discounted using a rate the Company believes is appropriate given the inherent risks associated with each intangible asset and reflect market participant assumptions.

The Company identified two intangible assets in connection with the GreenLine acquisition: trade names and trademarks valued at $36.0 million, which are considered to be indefinite life assets and therefore, will not be amortized; and customer base valued at $7.5 million with a thirteen year useful life. The trade name/trademark intangible asset was valued using the relief from royalty valuation method and the customer relationship intangible asset was valued using the distributor method.

Goodwill

The excess of the consideration transferred over the fair values assigned to the assets acquired and liabilities assumed was $13.2 million on the closing date, which represents the goodwill amount resulting from the acquisition which can be attributable to GreenLine’s long history, future prospects and the expected operating synergies from combining GreenLine with Apio’s fresh-cut, value-added vegetable business. None of the goodwill is expected to be deductible for income tax purposes. The Company will test goodwill for impairment on an annual basis or sooner, if indicators of impairment are present.

Deferred Tax Liabilities

The $1.9 million of net deferred tax liabilities resulting from the acquisition was primarily related to the difference between the book basis and tax basis of the intangible assets and net operating losses that were assumed by the Company in the acquisition.

“Acquisition-Related Transaction Costs

The Company recognized $1.4 million of acquisition-related expenses that were expensed in the year ended May 27, 2012 and are included in other operating expenses in the Consolidated Statements of Comprehensive Income for the year ended May 27, 2012. These expenses included investment banker fees, legal, accounting and tax service fees and appraisals fees.

Lifecore Biomedical, Inc.

On April 30, 2010, the Company acquired all of the common stock of Lifecore under a Stock Purchase Agreement (“Lifecore Purchase Agreement”) in order to expand its product offerings and enter into new markets. Lifecore was a privately-held HA-based biomaterials company located in Chaska, Minnesota. Lifecore is principally involved in the development and manufacture of products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans.

Under the Lifecore Purchase Agreement, the Company paid to the former Lifecore stockholder at closing $40.0 million in cash. In addition to the cash consideration paid to the former shareholder of Lifecore, the Lifecore Purchase Agreement included an earn out payment of up to an additional $10.0 million based on Lifecore achieving certain revenue targets in calendar years 2011 and 2012. These revenue targets where achieved in calendar year 2011 and the $10.0 million earn out payment was paid by the Company to the former shareholder of Lifecore on May 29, 2012.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1383-128463

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 88-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph F4
-Subparagraph e
-Appendix F

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51, 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 67-73
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 3 - Sale of Landec Ag

12 Months Ended

May 26, 2013

Business Combinations [Abstract]

Mergers, Acquisitions and Dispositions Disclosures [Text Block]

3. Sale of Landec Ag

On June 24, 2012, Landec entered into a stock purchase agreement and two licensing agreements (see Note 5) with INCOTEC^® Coating and Seed Technology Companies (“INCOTEC”), a leading provider of seed and coating technology products and services to the seed industry.

In the stock purchase agreement, Landec sold its equity interest in its seed subsidiary, Landec Ag LLC, to INCOTEC for $600,000, which resulted in a gain of $400,000. Under accounting guidance, because the stock purchase agreement was entered into at the same time the license agreements were consummated (a multiple element agreement), a portion of the gain, or $300,000, has been deferred and will be recognized as revenue monthly from the sale date over the seven year life of the Pollinator Plus® license agreement (see Note 5). The remaining $100,000 of the gain was recognized during the first quarter of fiscal year 2013.

Note 4 - Investments in Non-public Companies

12 Months Ended

May 26, 2013

Investment Holdings [Abstract]

Investment Holdings [Text Block]

4. Investments in non-public companies

In December 2005, Landec entered into an exclusive licensing agreement with Aesthetic Sciences for the exclusive rights to use Landec's Intelimer materials technology for the development of dermal fillers worldwide under the agreement. The Company received shares of preferred stock in exchange for the license with a valuation of $1.8 million. Aesthetic Sciences sold the rights to its Smartfil Injector System on July 16, 2010. Landec has evaluated its investment in Aesthetic Sciences for impairment, utilizing a discounted cash flow analysis under the terms of the purchase agreement. Based on the terms of the sale, the Company determined that its investment was other than temporarily impaired and therefore, recorded an impairment charge of $1.0 million in fiscal year 2010. The Company’s carrying value of its investment in Aesthetic Sciences is $793,000 as of May 26, 2013 and May 27, 2012. No additional impairment has been determined for the Company’s investment in Aesthetic Sciences.

On February 15, 2011, Apio entered into a share purchase agreement (the “Windset Purchase Agreement”) with Windset. Pursuant to the Windset Purchase Agreement, Apio purchased 150,000 senior preferred shares for $15 million and 201 common shares for $201 that were issued by Windset (the “Purchased Shares”). The Company’s common shares represent a 20.1% interest in Windset. The non-voting senior preferred shares yield a cash dividend of 7.5% annually. The dividend is payable within 90 days of each anniversary of the execution of the Windset Purchase Agreement, the first two dividend payments of $1.1 million each were made in May 2013 and May 2012. The Windset Purchase Agreement includes a put and call option, which can be exercised on the sixth anniversary of the Windset Purchase Agreement whereby Apio can exercise the put to sell its Purchased Shares to Windset, or Windset can exercise the call to purchase the Purchased Shares from Apio, in either case, at a price equal to 20.1% of the appreciation in the fair market value of Windset from the date of the Company’s investment through the put and call date, plus the purchase price of the Purchased Shares. Under the terms of the arrangement with Windset, the Company is entitled to designate one of five members on the Board of Directors of Windset.

In accordance with accounting guidance, the investment in Windset does not qualify for equity method accounting as the investment does not meet the criteria of in-substance common stock due to returns through the annual dividend on the non-voting senior preferred shares that are not available to the common stock holders. As the put and call options require the Purchased Shares to be put or called in equal proportions, the Company has deemed that the investment, in substance, should be treated as a single security for purposes of accounting. The Company has adopted fair value option in the accounting for its investment in Windset effective on the acquisition date. The fair value of the Company’s investment in Windset utilizes significant unobservable inputs in the discounted cash flow models, including projected cash flows, growth rates and the discount rate, and is therefore considered a Level 3 for fair value measurement purposes (see Note 1). The Company believes that reporting its investment at fair value provides its investors with useful information on the performance of the Company’s investment and the anticipated appreciation in value as Windset expands its business.

The fair value of the Company’s investment in Windset was determined utilizing a discounted cash flow model based on projections developed by Windset, and considers the put and call conversion options. These features impact the duration of the cash flow utilized to derive the estimated fair value of the investment. Assumptions included in the discounted cash flow model will be evaluated quarterly based on Windset’s actual and projected operating results to determine the change in fair value.

During fiscal years 2013 and 2012, the Company recorded and received in cash $1.1 million in dividend income and the Company recorded $8.1 million and $5.8 million of income, respectively, which is included in other income in the Consolidated Statements of Comprehensive Income, from the increase in the fair market value of the Company’s investment in Windset. From the close of the Windset Purchase Agreement on February 15, 2011 to May 29, 2011, the Company recorded $328,000 in dividend income and $662,000 from the increase in the fair market value of the Company’s investment in Windset.

The Company also entered into an exclusive license agreement with Windset, which was executed in June 2010, prior to contemplation of Apio’s investment in Windset (see Note 5).

Note 5 - License Agreements

12 Months Ended

May 26, 2013

License Agreements [Abstract]

License Agreements [Text Block]

5. License Agreements

Monsanto

On December 1, 2006, Landec entered into a five-year co-exclusive technology license and polymer supply agreement (“the Monsanto Agreement”) with Monsanto Company (“Monsanto”) for the use of Landec’s Intellicoat polymer seed coating technology. On December 1, 2011, Monsanto terminated the Monsanto Agreement and paid the Company a $4 million termination fee and all rights to the Intellicoat seed coating technology reverted to Landec.

For fiscal years 2013, 2012 and 2011, Landec recognized license revenues from the Monsanto Agreement of zero, $2.7 million and $5.4 million, respectively.

INCOTEC

In connection with the sale of Landec Ag to INCOTEC on June 24, 2012 (see Note 3), Landec entered into a seven-year exclusive technology license and polymer supply agreement with INCOTEC for the use of Landec’s Intellicoat^® polymer seed coating technology for male inbred corn which is sold under the Pollinator Plus label. This license does not include the use of Intellicoat for the controlled release of an active ingredient for agricultural applications which was retained by Landec. Landec will be the exclusive supplier of Pollinator Plus polymer to INCOTEC during the term of the license agreement. Landec will receive a royalty equal to 20% of the revenues realized by INCOTEC from the sale of or sublicense of Pollinator Plus coatings during the first four years of the agreement and 10% for the last three years of the agreement.

On June 24, 2012, Landec also entered into a five-year exclusive technology license and polymer supply agreement with INCOTEC for the joint development of new polymer and unique coatings for use in seed treatment formulations. In this agreement, Landec will receive a value share which will be mutually agreed to by both parties prior to each application being developed.

Air Products

In March 2006, Landec entered into an exclusive license and research and development agreement with Air Products and Chemicals, Inc. (“Air Products”). In accordance with the agreement, Landec receives 40% of the direct profit generated from the sale of products by Air Products occurring after April 1, 2007, that incorporate Landec’s Intelimer materials.

Chiquita

In September 2007, the Company amended its licensing and supply agreement with Chiquita Brands International, Inc. (“Chiquita”). Under the terms of the amendment, the license for bananas was expanded to include additional exclusive fields using Landec’s BreatheWay® packaging technology, and a new exclusive license was added for the sale and marketing of avocados and mangos using Landec’s BreatheWay packaging technology. The agreement with Chiquita has been renewed through December 2016 and requires Chiquita to pay annual gross profit minimums to Landec in order for Chiquita to maintain its exclusive license for bananas, avocados and mangos. Under the terms of the agreement, Chiquita must notify Landec before December 1^st of each year whether it is going to maintain its exclusive license for the following calendar year and thus agree to pay the minimums for that year. Landec was notified in November 2012 that Chiquita had chosen to not maintain its exclusive license for calendar year 2013 and thus was not required to pay the minimum gross profit for calendar year 2013. As a result, the agreement has reverted to a non-exclusive agreement in which Chiquita will pay the Company for membranes purchased on a per unit sales basis and the Company is now entitled to sell its BreatheWay packaging technology for bananas, avocados and mangos to others.

Windset

In June 2010, Apio entered into an exclusive license agreement with Windset for Windset to utilize Landec’s proprietary breathable packaging to extend the shelf life of greenhouse grown cucumbers, peppers and tomatoes (“Exclusive Products”). In accordance with the agreement, Apio received and recorded a one-time upfront research and development fee of $100,000 and will receive license fees equal to 3% of net revenue of the Exclusive Products utilizing the proprietary breathable packaging technology, with or without the BreatheWay trademark. The ongoing license fees are subject to annual minimums of $150,000 for each of the three types of exclusive product as each is added to the agreement. As of May 26, 2013, two products have been added to the agreement.

Nitta

In July 2012, the Company entered into an agreement with Nitta Corporation (“Nitta”), a Japanese company, to develop additional uses of the Company’s adhesive polymer technology for electronics. During fiscal year 2013, the Company recognized $688,000 in research and development revenues from this agreement.

Note 6 - Property and Equipment

12 Months Ended

May 26, 2013

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

6. Property and Equipment

Property and equipment consists of the following (in thousands):

	Years of Useful Life			May 26, 2013			May 27, 2012
Land and building	15	-	30	$	52,527		$	51,993
Leasehold improvements	3	-	20		1,029			1,103
Computer, capitalized software, machinery, equipment and auto	3	-	7		47,066			43,094
Furniture and fixtures	5	-	7		766			551
Construction in process					3,355			727
Gross property and equipment					104,743			97,468
Less accumulated depreciation and amortization					(38,932	)		(33,973	)
Net property and equipment				$	65,811		$	63,495

Depreciation and amortization expense for property and equipment for the fiscal years ended May 26, 2013, May 27, 2012 and May 29, 2011 was $6.3 million, $5.3 million and $5.0 million, respectively. There were no equipment under capital leases at May 26, 2013. Equipment under capital leases totaled $158,000 at May 27, 2012 and the related accumulated amortization as of May 27, 2012 was zero as these leases were assumed in the acquisition of GreenLine on April 23, 2012. Amortization related to capitalized software was $160,000, $136,000 and $136,000 for fiscal years ended May 26, 2013, May 27, 2012 and May 29, 2011, respectively. The unamortized computer software costs at May 26, 2013 and May 27, 2012 were $343,000 and $468,000, respectively.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details

Note 7 - Intangible Assets

12 Months Ended

May 26, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

7. Intangible Assets

Changes in the carrying amount of goodwill for the fiscal years ended May 26, 2013, May 27, 2012 and May 29, 2011 by reportable segment, are as follows (in thousands):

	Food Products Technology		Corporate			Hyaluronan- based Biomaterials		Total

Balance as of May 30, 2010	$	22,581	$	4,780		$	13,793	$	41,154
Goodwill acquired/reclassified during the period		—		—			88		88
Goodwill impaired during the period		—		(4,780	)		—		(4,780	)
Balance as of May 29, 2011		22,581		—			13,881		36,462
Goodwill acquired during the period		13,158		—			—		13,158
Balance as of May 27, 2012		35,739		—			13,881		49,620
Goodwill acquired during the period		—		—			—		—
Balance as of May 26, 2013	$	35,739	$	—		$	13,881	$	49,620

Information regarding Landec’s other intangible assets is as follows (in thousands):

	Trademarks & Trade names		Customer Relationships			Total
Balance as of May 30, 2010		12,428		3,674			16,102
Amortization expense		—		(308	)		(308	)
Balance as of May 29, 2011		12,428		3,366			15,794
Acquired during the period		36,000		7,500			43,500
Amortization expense		—		(309	)		(309	)
Balance as of May 27, 2012		48,428		10,557			58,985
Amortization expense		—		(951	)		(951	)
Balance as of May 26, 2013	$	48,428	$	9,606		$	58,034

Accumulated amortization of Trademarks and Tradenames as of May 26, 2013 and May 27, 2012 was $872,000. Accumulated amortization of Customer Relationships as of May 26, 2013 and May 27, 2012 was $1.6 million and $643,000, respectively. Accumulated impairment losses as of May 26, 2013 and May 27, 2012 were $4.8 million. Lifecore’s customer relationships amount of $3.7 million is being amortized over 12 years and GreenLine’s customer relationships amount of $7.5 million is being amortized over 13 years. The amortization expense for the next five fiscal years is estimated to be $885,000 per year.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Note 8 - Stockholders' Equity

12 Months Ended

May 26, 2013

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

8. Stockholders’ Equity

Holders of Common Stock are entitled to one vote per share.

Convertible Preferred Stock

The Company has authorized two million shares of preferred stock, and as of May 26, 2013 has no outstanding preferred stock.

Common Stock and Stock Option Plans

At May 26, 2013, the Company had 1.9 million common shares reserved for future issuance under Landec equity incentive plans.

On October 15, 2009, following stockholder approval at the Annual Meeting of Stockholders of the Company, the 2009 Stock Incentive Plan (the “Plan”) became effective and replaced the Company’s 2005 Stock Incentive Plan. Employees (including officers), consultants and directors of the Company and its subsidiaries and affiliates are eligible to participate in the Plan.

The Plan provides for the grant of stock options (both nonstatutory and incentive stock options), stock grants, stock units and stock appreciation rights. Awards under the Plan will be evidenced by an agreement with the Plan participants and 1.9 million shares of the Company’s Common Stock (“Shares”) were initially available for award under the Plan. Under the Plan, no recipient may receive awards during any fiscal year that exceeds the following amounts: (i) stock options covering in excess of 500,000 Shares; (ii) stock grants and stock units covering in excess of 250,000 Shares in the aggregate; or (iii) stock appreciation rights covering more than 500,000 Shares. In addition, awards to non-employee directors are discretionary. However, a non-employee director may not be granted awards in excess of 30,000 Shares in the aggregate during any fiscal year. The exercise price of the options was the fair market value of the Company’s Common Stock on the date the options were granted.

On October 14, 2005, following stockholder approval at the Annual Meeting of Stockholders of the Company, the 2005 Stock Incentive Plan (“2005 Plan”) became effective. The 2005 Plan replaced the Company’s four then existing equity plans and no shares remain available for grant under those plans. Employees (including officers), consultants and directors of the Company and its subsidiaries and affiliates were eligible to participate in the 2005 Plan. The 2005 Plan provided for the grant of stock options (both nonstatutory and incentive stock options), stock grants, stock units and stock appreciation rights. Under the 2005 Plan, 861,038 Shares were initially available for awards, and as of May 26, 2013, 344,300 options to purchase shares remain outstanding. The exercise price of the options was the fair market value of the Company’s Common Stock on the date the options were granted.

The 1995 Directors’ Stock Option Plan (the “Directors’ Plan”) provided that each person who became a non- employee director of the Company, who had not received a previous grant, be granted a nonstatutory stock option to purchase 20,000 shares of Common Stock on the date on which the optionee first became a non-employee director of the Company. Thereafter, on the date of each annual meeting of the stockholders each non-employee director was granted an additional option to purchase 10,000 shares of Common Stock if, on such date, he or she had served on the Company’s Board of Directors for at least six months prior to the date of such annual meeting. The exercise price of the options was the fair market value of the Company’s Common Stock on the date the options were granted. Options granted under this plan were exercisable and vested upon grant.

The 1996 Non-Executive Stock Option Plan authorized the Board of Directors to grant non-qualified stock options to employees, including executive officers, and outside consultants of the Company. The exercise price of the options was equal to the fair market value of the Company’s Common Stock on the date the options were granted.

Options were generally exercisable upon vesting and generally vested ratably over four years and were subject to repurchase if exercised before being vested.

The 1996 Stock Option Plan authorized the Board of Directors to grant stock purchase rights, incentive stock options or non-statutory stock options to Landec executives. The exercise price of the stock purchase rights, incentive stock options and non-statutory stock options could be no less than 100% of the fair market value of Landec’s Common Stock on the date the options were granted. Options generally were exercisable upon vesting, generally vested ratably over four years and were subject to repurchase if exercised before being vested.

Activity under all Landec equity incentive plans is as follows:

Stock-Based Compensation Activity

				Restricted Stock Outstanding					Stock Options Outstanding
	RSUs and Options Available for Grant			Number of Restricted Shares			Weighted Average Grant Date Fair Value		Number of Stock Options			Weighted Average Exercise Price
Balance at May 30, 2010		770,311			431,605		$	6.35		2,456,829		$	6.13
Granted		(129,335	)		32,335		$	6.00		97,000		$	6.00
Awarded/Exercised		—			(48,855	)	$	9.48		(217,076	)	$	3.46
Forfeited		—			—			—		(18,000	)	$	10.63
Balance at May 29, 2011		640,976			415,085		$	5.96		2,318,753		$	6.34
Granted		(191,333	)		47,833		$	6.67		143,500		$	6.67
Awarded/Exercised		—			(111,252	)	$	6.36		(371,727	)	$	5.40
Forfeited		—			(3,500	)	$	5.84		(5,657	)	$	5.76
Plan shares expired		—			—			—		(38,437	)	$	8.23
Balance at May 27, 2012		449,643			348,166		$	5.93		2,046,432		$	6.50
Granted		(26,666	)		6,666		$	9.01		20,000		$	9.01
Awarded/Exercised		—			(231,086	)	$	5.74		(671,563	)	$	6.30
Forfeited		—			(28,416	)	$	6.20		(44,977	)	$	6.34
Plan shares expired		—			—			—		(10,000	)	$	13.32
Balance at May 26, 2013		422,977			95,330		$	6.52		1,339,892		$	6.58

Upon vesting of certain RSUs and the exercise of certain options during fiscal years 2013, 2012 and 2011, certain RSUs and exercised options were net share-settled to cover the required exercise price and withholding tax and the remaining amounts were converted into an equivalent number of shares of Common Stock. The Company withheld shares with value equivalent to the exercise price for options and the employees' minimum statutory obligation for the applicable income and other employment taxes, and remitted the cash to the appropriate taxing authorities. The total shares withheld for fiscal years 2013, 2012 and 2011 were 145,159, 326,954 and 136,374 RSUs and options, respectively, which was based on the value of the option and/or RSUs on their exercise or vesting date as determined by the Company's closing stock price. Total payments for the employees' tax obligations to the taxing authorities during fiscal year 2013 were approximately $49,000. These net-share settlements had the effect of share repurchases by the Company as they reduced and retired the number of shares that would have otherwise have been issued as a result of the vesting and did not represent an expense to the Company.

The following table summarizes information concerning stock options outstanding and exercisable at May 26, 2013:

			Options Outstanding							Options Exercisable
Range of Exercise Prices			Number of Shares Outstanding	Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Aggregate Intrinsic Value		Number of Shares Exercisable		Weighted Average Exercise Price		Aggregate Intrinsic Value
$5.63	-	$5.63	423,101		4.00	$	5.63	$	3,490,583		423,101	$	5.63	$	3,490,583
$5.65	-	$6.22	367,135		3.57	$	6.15	$	2,836,564		359,005	$	6.16	$	2,772,504
$6.35	-	$7.50	443,656		2.89	$	6.77	$	3,153,362		391,496	$	6.79	$	2,776,788
$8.19	-	$13.32	106,000		2.31	$	11.09	$	296,110		89,332	$	11.47	$	214,937
$5.63	-	$13.32	1,339,892		3.38	$	6.58	$	9,776,619		1,262,934	$	6.55	$	9,254,812

The weighted average remaining contractual life of options exercisable as of May 26, 2013 was 3.01 years.

At May 26, 2013 and May 27, 2012 options to purchase 1,262,934 and 1,620,562 shares of Landec’s Common Stock were vested, respectively. No options have been exercised prior to being vested. The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on the Company’s closing stock price of $13.88 on May 24, 2013, which would have been received by holders of stock options had all holders of stock options exercised their stock options that were in-the-money as of that date. The total number of in-the-money stock options exercisable as of May 26, 2013, was 1,262,934 shares. The aggregate intrinsic value of stock options exercised during the fiscal year 2013 was $4.1 million.

Shares Subject to Vesting

The following table summarizes the activity relating to unvested stock option grants and RSUs during the fiscal year ended May 26, 2013:

	Stock Options					Restricted Stock
	Shares			Weighted Average Fair Value		Shares			Weighted Average Fair Value
Unvested at May 27, 2012		425,870		$	2.43		348,166		$	5.93
Granted		20,000		$	3.57		6,666		$	9.01
Vested/Awarded		(323,935	)	$	2.87		(231,086	)	$	5.74
Forfeited		(44,977	)	$	—		(28,416	)	$	6.20
Unvested at May 26, 2013		76,958		$	2.29		95,330		$	6.52

As of May 26, 2013, there was $418,000 of total unrecognized compensation expense related to unvested equity compensation awards granted under the Company’s incentive stock plans. Total expense is expected to be recognized over the weighted-average period of 2.0 years for stock options and 1.7 years for restricted stock awards.

Stock Repurchase Plan

On July 14, 2010, the Board of Directors of the Company approved the establishment of a stock repurchase plan which allows for the repurchase of up to $10 million of the Company’s Common Stock. The Company may repurchase its common stock from time to time in open market purchases or in privately negotiated transactions. The timing and actual number of shares repurchased is at the discretion of management of the Company and will depend on a variety of factors, including stock price, corporate and regulatory requirements, market conditions, the relative attractiveness of other capital deployment opportunities and other corporate priorities. The stock repurchase program does not obligate Landec to acquire any amount of its common stock and the program may be modified, suspended or terminated at any time at the Company's discretion without prior notice. During fiscal year 2013, the Company did not purchase any shares on the open market. During fiscal year 2012, the Company purchased on the open market 917,244 shares of its Common Stock for $5.0 million and retired those shares. During fiscal year 2011, the Company purchased on the open market 215,684 shares of its Common Stock for $1.2 million and retired those shares.

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Section B
-Paragraph 7, 11A
-Chapter 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 23: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Note 9 - Debt

12 Months Ended

May 26, 2013

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

9. Debt

Long-term debt consists of the following (in thousands):

	May 26, 2013			May 27, 2012
Real estate loan agreement with General Electric Capital Corporation (“GE Capital”); due in monthly principal and interest payments of $133,060 through May 1, 2022 with interest based on a fixed rate of 4.02% per annum	$	17,065		$	17,957
Real estate bridge loan agreement with GE Capital; due in monthly principal and interest payments of $8,902 with a lump sum final principal payment due on May 1, 2013 with interest based on a fixed rate of 4.02% per annum		—			1,200
Capital equipment loan with GE Capital; due in monthly principal and interest payments of $175,356 through May 1, 2019 with interest based on a fixed rate of 4.39% per annum		11,080			12,660
Term note with BMO Harris; due in monthly payments of $250,000 through May 23, 2016 with interest payable monthly at LIBOR plus 2% per annum		9,000			12,000
Industrial revenue bonds (“IRBs”) issued by Lifecore; due in annual payments through 2020 with interest at a variable rate set weekly by the bond remarketing agent (0.38% and 0.42% at May 26, 2013 and May 27, 2012, respectively)		3,160			3,500
Total		40,305			47,317
Less current portion		(5,933	)		(7,012	)
Long-term portion	$	34,372		$	40,305

The future minimum principal payments of the Company’s debt for each year presented are as follows (in thousands):

	GE RE Loan		GE Equipment		BMO Harris		IRB		Total

FY 2014	$	928	$	1,650	$	3,000	$	355	$	5,933

FY 2015		966		1,725		3,000		365		6,056

FY 2016		1,005		1,801		3,000		375		6,181

FY 2017		1,047		1,882		—		390		3,319

FY 2018		1,089		1,967		—		400		3,456

Thereafter		12,030		2,055		—		1,275		15,360

Total	$	17,065	$	11,080	$	9,000	$	3,160	$	40,305

In addition to entering into the GE real estate and equipment loans mentioned above, on April 23, 2012 in connection with the acquisition of GreenLine, Apio also entered into a five-year, $25.0 million asset-based working capital revolving line of credit, with an interest rate of LIBOR plus 2%, with availability based on the combination of the eligible accounts receivable and eligible inventory (availability was $14.6 million at May 26, 2013). Apio’s revolving line of credit has an unused fee of 0.375% per annum. At May 26, 2013 and May 27, 2012, Apio had $4.0 million and $11.7 million, respectively, outstanding under its revolving line of credit.

The GE real estate, equipment and line of credit agreements (collectively the “GE Debt Agreements”) are secured by liens on all of the property of Apio and its subsidiaries. The GE Debt Agreements contain customary events of default under which obligations could be accelerated or increased. The GE Debt Agreements are guaranteed by Landec and Landec has pledged its equity interest in Apio as collateral under the agreements. Apio was in compliance with all financial covenants as of May 26, 2013. Unamortized loan origination fees for the GE Debt Agreements were $1.2 million and $1.3 million at May 26, 2013 and May 27, 2012, respectively, and are included in other assets in the Consolidated Balance Sheets. Amortization of loan origination fees recorded to interest expense for fiscal years 2013, 2012 and 2011 were $181,000, $15,000 and zero, respectively.

On May 23, 2012, Lifecore entered into two financing agreements with BMO Harris Bank N.A. and/or its affiliates (“BMO Harris”), collectively (the “Lifecore Loan Agreements”):

A Credit and Security Agreement (the “Credit Agreement”) which includes (a) a one-year, $8.0 million asset-based working capital revolving line of credit, with an interest rate of LIBOR plus 1.85%, with availability based on the combination of Lifecore’s eligible accounts receivable and inventory balances (availability was $7.0 million at May 26, 2013) and with no unused fee (at May 26, 2013 and May 27, 2012, no amounts were outstanding under the line of credit) and (b) a $12.0 million term loan which matures in four years due in monthly payments of $250,000 with interest payable monthly based on a variable interest rate of LIBOR plus 2% (the “Term Loan”).

A Reimbursement Agreement pursuant to which BMO Harris caused its affiliate Bank of Montreal to issue an irrevocable letter of credit in the amount of $3.5 million (the “Letter of Credit”) which is securing the IRB described below.

The obligations of Lifecore under the Lifecore Loan Agreements are secured by liens on all of the property of Lifecore. The Lifecore Loan Agreements contain customary covenants, such as limitations on the ability to (1) incur indebtedness or grant liens or negative pledges on Lifecore’s assets; (2) make loans or other investments; (3) pay dividends or repurchase stock or other securities; (4) sell assets; (5) engage in mergers; (6) enter into sale and leaseback transactions; (7) adopt certain benefit plans; and (8) make changes in Lifecore’s corporate structure. In addition, under the Credit Agreement, Lifecore must maintain (a) a minimum fixed charge coverage ratio of 1.10 to 1.0 and a minimum quick ratio of 1.25 to 1.00, both of which must be satisfied as of the end of each fiscal quarter commencing with the fiscal quarter ending August 26, 2012 and (b) a minimum tangible net worth of $29,000,000, measured as of May 28, 2013, and as of the end of each fiscal year thereafter. Unamortized loan origination fees for the Lifecore Loan Agreements were $149,000 and $139,000 at May 26, 2013 and May 27, 2012, respectively, and are included in other assets in the Consolidated Balance Sheets. Amortization of loan origination fees recorded to interest expense for fiscal year 2013, 2012 and 2011 were $50,000, $161,000 and $45,000 respectively. Lifecore was in compliance with all financial covenants as of May 26, 2013.

The market value of the Company’s debt approximates its recorded value as the interest rates on each debt instrument approximates current market rates.

The Term Loan was used to repay Lifecore’s former credit facility with Wells Fargo Bank, N.A. (“Wells Fargo”). The Letter of Credit (which replaces a letter of credit previously provided by Wells Fargo) provides liquidity

and credit support for the IRBs.

On August 19, 2004, Lifecore issued variable rate industrial revenue bonds (“IRBs”). These IRBs were assumed by Landec in the acquisition of Lifecore (see Note 2). The IRBs are collateralized by a bank letter of credit which is secured by a first mortgage on the Company’s facility in Chaska, Minnesota. In addition, the Company pays an annual remarketing fee equal to 0.125% and an annual letter of credit fee of 0.75%. The maturities on the IRBs are held in a sinking fund account, recorded in Other Current Assets in the accompanying Consolidated Balance Sheets, and are paid out each year on September 1^st.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References + Details

Note 10 - Derivative Financial Instruments

12 Months Ended

May 26, 2013

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

10. Derivative Financial Instruments

In May 2010, the Company entered into a five-year interest rate swap agreement under the credit agreement with Wells Fargo, which expires on April 30, 2015. The interest rate swap was designated as a cash flow hedge of future interest payments of LIBOR and had a notional amount of $20 million. As a result of the interest rate swap transaction, the Company fixed for a five-year period the interest rate at 4.24% subject to market based interest rate risk on $20 million of borrowings under the credit agreement with Wells Fargo. The Company’s obligations under the interest rate swap transaction as to the scheduled payments were guaranteed and secured on the same basis as its obligations under the credit agreement with Wells Fargo at the time the agreement was consummated. Upon entering into the new Term Loan with BMO Harris, the Company used the proceeds from that loan to pay off the Wells Fargo credit facility. The swap with Wells Fargo was not terminated upon the extinguishment of the debt with Wells Fargo. As a result of extinguishing the debt with Wells Fargo as of May 23, 2012, the swap was no longer an effective hedge and therefore, the fair value of the swap at the time the debt was extinguished of $347,000 was reversed from other comprehensive income and recorded in other expense during fiscal year 2012. The fair value of the swap arrangement as of May 26, 2013 and May 27, 2012 was $163,000 and $347,000, respectively, and is included in other accrued liabilities in the accompanying Consolidated Balance Sheets.

- Definition

The entire disclosure for the entity's entire derivative instruments and hedging activities. Describes an entity's risk management strategies, derivatives in hedging activities and non-hedging derivative instruments, the assets, obligations, liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624177-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708775-113959

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80748-113994

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41635-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708773-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5580258-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624181-113959

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 11 - Income Taxes

12 Months Ended

May 26, 2013

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

11. Income Taxes

The provision for income taxes consisted of the following (in thousands):

	Year ended May 26, 2013			Year ended May 27, 2012			Year ended May 29, 2011
Current:
Federal	$	2,808		$	4,597		$	881
State		(18	)		(586	)		176
Foreign		56			56			—
Total		2,846			4,067			1,057
Deferred:
Federal		6,218			2,641			3,140
State		388			477			(16	)
Total		6,606			3,118			3,124
Income tax expense	$	9,452		$	7,185		$	4,181

The actual provision for income taxes differs from the statutory U.S. federal income tax rate as follows (in thousands):

	Year Ended May 26, 2013			Year Ended May 27, 2012			Year Ended May 29, 2011
Provision at U.S. statutory rate (1)	$	11,214		$	6,958		$	2,835
State income taxes, net of federal benefit		731			451			213
Goodwill impairment charge		—			—			1,849
Change in valuation allowance		370			1			(7	)
Tax-exempt interest		—			(40	)		(115	)
Tax credit carryforwards		(801	)		(368	)		(637	)
Transaction costs		—			322			—
Domestic manufacturing deduction		(172	)		(208	)		—
Change in value of contingent consideration		(1,450	)		—			—
Other		(440	)		69			43
Total	$	9,452		$	7,185		$	4,181

(1) Statutory rate was 35% for fiscal years 2013, 2012 and 2011.

The increase in the income tax expense in fiscal year 2013 compared to fiscal year 2012 is due to a 59% increase in net income before taxes offset by a decrease in the Company’s effective tax rate to 30% down from 36% in fiscal year 2012. The increase in the income tax expense in fiscal year 2012 compared to fiscal year 2011 is due to a 140% increase in net income before taxes partially offset by a decrease in the Company’s effective tax rate to 36% down from 52% in fiscal year 2011.

The effective tax rates for fiscal year 2013 differ from the statutory federal income tax rate of 35 percent as a result of several factors, including state taxes, change in value of contingent consideration, non-deductible stock-based compensation expense, disqualified dispositions of incentive stock options, domestic manufacturing deduction, the benefit of federal and state research and development credits and the change in valuation allowance. The effective tax rates for fiscal year 2012 differ from the statutory federal income tax rate of 35 percent as a result of several factors, including state taxes, non-deductible stock-based compensation expense, tax exempt interest, domestic manufacturing deduction and the benefit of federal and state research and development credits and accounting for transaction costs associated with the GreenLine acquisition in fiscal year 2012. The effective tax rates for fiscal year 2011 differ from the statutory federal income tax rate of 35 percent as a result of several factors, including state taxes, non-deductible stock-based compensation expense, tax exempt interest and the goodwill impairment charge. In addition to the above, the Company was able to further reduce the effective tax rate for fiscal year 2011 as a result of being a recipient of a therapeutic drug credit award and the extension of the federal research and development credit.

Significant components of deferred tax assets and liabilities consisted of the following (in thousands):

	May 26, 2013			May 27, 2012
Deferred tax assets:
Net operating loss carryforwards	$	3,853		$	3,954
Accruals and reserves		1,388			2,191
Stock-based compensation		621			981
Research and AMT credit carryforwards		486			328
Other		450			428
Gross deferred tax assets		6,798			7,882
Valuation allowance		(783	)		(419	)
Net deferred tax assets		6,015			7,463

Deferred tax liabilities:
Basis difference in investment in non-public company		(5,505	)		(2,510	)
Depreciation and amortization		(5,822	)		(5,575	)
Goodwill and other indefinite life intangibles		(17,160	)		(15,339	)
Deferred tax liabilities		(28,487	)		(23,424	)

Net deferred tax liabilities	$	(22,472	)	$	(15,961	)

As of May 26, 2013, the Company had federal, California, and other state net operating loss carryforwards of approximately $8.8 million, $4.6 million, and $15.2 million respectively. These losses expire in different periods through 2032, if not utilized. Such net operating losses consist of excess tax benefits from employee stock option exercises and have not been recorded in the Company’s deferred tax assets. The Company will record approximately $4.6 million of the gross California net operating loss as a credit to additional paid in capital as and when such excess tax benefits are ultimately realized. The Company acquired additional net operating losses through the acquisition of Greenline. Utilization of these acquired net operating losses in a specific year is limited due to the “change in ownership” provision of the Internal Revenue Code of 1986 and similar state provisions. The net operating losses presented above for federal and state purposes are net of any such limitation.

The Company has federal and state research and development tax credits carryforwards of approximately $118,000 and $1.2 million, respectively. The research and development tax credit carryforwards expire in different periods through 2033 for federal purposes and have an unlimited carryforward period for state purposes. The Company also has federal therapeutic drug tax credit carryforward of approximately $244,000 that will expire in 2031. Furthermore, the Company has federal alternative minimum tax credits of approximately $874,000 that can be carried forward indefinitely. Certain tax credit carryovers are attributable to excess tax benefits from employee stock option exercises and have not been recorded in the Company’s deferred tax assets. The Company will record $1.2 million of the above Federal credit and $338,000 of the gross California credit will be recorded to additional paid in capital as and when such excess tax benefits are ultimately realized.

Valuation allowances are reviewed each period on a tax jurisdiction by jurisdiction basis to analyze whether there is sufficient positive or negative evidence to support a change in judgment about the realizability of the related deferred tax assets. Based on this analysis and considering all positive and negative evidence, we determined that a valuation allowance of $783,000 should be recorded as a result of uncertainty around the utilization of certain state net operating losses and a book impairment loss on the Company's investment in Aesthetic Sciences as it is more likely than not that a portion of the deferred tax asset will not be realized in the foreseeable future. The valuation allowance increased by $364,000 from the prior year primarily due to uncertainty around the utilization of certain state net operating losses.

The accounting for uncertainty in income taxes recognized in an enterprise’s financial statements prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and the derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure, and transition.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):

	As of
	May 26, 2013		May 27, 2012			May 29, 2011
Unrecognized tax benefits – beginning of the period	$	766	$	760		$	868
Gross increases – tax positions in prior period		103		1			280
Gross decreases – tax positions in prior period		—		(1	)		(310	)
Gross increases – current-period tax positions		129		246			75
Settlements		—		—			—
Lapse of statute of limitations		—		(240	)		(153	)
Unrecognized tax benefits – end of the period	$	998	$	766		$	760

As of May 26, 2013, the total amount of net unrecognized tax benefits is $1.0 million, of which, $807,000, if recognized, would affect the effective tax rate. The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. The total amount of penalties and interest is not material as of May 26, 2013. Additionally, the Company does not expect its unrecognized tax benefits to change materially within the next twelve months.

Due to tax attribute carryforwards, the Company is subject to examination for tax years 1997 forward for U.S. tax purposes. The Company is also subject to examination in various state jurisdictions for tax years 1998 forward, none of which were individually material.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

+ Details

Note 12 - Commitments and Contingencies

12 Months Ended

May 26, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

12. Commitments and Contingencies

Operating Leases

Landec leases facilities and equipment under operating lease agreements with various terms and conditions, which expire at various dates through fiscal year 2019. Certain of these leases have various renewal options.

The approximate future minimum lease payments under these operating leases, excluding land leases, at May 26, 2013 are as follows (in thousands):

	Amount
FY2014	$	2,139
FY2015		1,730
FY2016		1,421
FY2017		1,135
FY2018		554
Thereafter		350
	$	7,329

Rent expense for operating leases, including month to month arrangements was $4.8 million, $1.5 million and $1.2 million for the fiscal years 2013, 2012 and 2011, respectively.

Capital Leases

There was no equipment under capital lease agreements at May 26, 2013.

Employment Agreements

Landec has entered into employment agreements with certain key employees. These agreements provide for these employees to receive incentive bonuses based on the financial performance of certain divisions in addition to their annual base salaries. The accrued incentive bonuses amounted to $548,000 at May 26, 2013 and $526,000 at May 27, 2012.

Purchase Commitments

At May 26, 2013, the Company was committed to purchase $2.2 million of produce during fiscal year 2014 in accordance with contractual terms at market rates. Payments of $9.5 million were made in fiscal year 2013 under these arrangements.

Loss Contingencies

As of May 26, 2013, the Company is not a party to any legal proceedings.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 13 - Employee Savings and Investment Plans

12 Months Ended

May 26, 2013

Compensation and Retirement Disclosure [Abstract]

Pension and Other Postretirement Benefits Disclosure [Text Block]

13. Employee Savings and Investment Plans

The Company sponsors a 401(k) plan which is available to substantially all of the Company’s employees. Landec’s Corporate Plan, which is available to all Landec employees (“Landec Plan”), allows participants to contribute from 1% to 50% of their salaries, up to the Internal Revenue Service (IRS) limitation into designated investment funds. The Company matches 67% on the first 6% contributed by an employee. Participants are at all times fully vested in their contributions. The Company's contribution vests annually over a four-year period at a rate of 25% per year. The Company retains the right, by action of the Board of Directors, to amend, modify, or terminate the plan. For fiscal years 2013, 2012 and 2011, the Company contributed $939,000, $789,000 and $720,000, respectively, to the Landec Plan.

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Implementation Guide (Q and A)
-Number FAS88
-Paragraph 63
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 03-2
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph q
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 8
-Subparagraph m
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 7, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS106-2
-Paragraph 20, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 30
-Paragraph 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 14 - Business Segment Reporting

12 Months Ended

May 26, 2013

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

14. Business Segment Reporting

The Company manages its business operations through three strategic business units. Based upon the information reported to the chief operating decision maker, who is the Chief Executive Officer, the Company has the following reportable segments: the Food Products Technology segment, the Food Export segment and the Hyaluronan-based Biomaterials segment.

The Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. In addition, the Food Products Technology segment sells BreatheWay packaging to partners for non-vegetable products. The Food Export segment consists of revenues generated from the purchase and sale of primarily whole commodity fruit and vegetable products to Asia and domestically. The HA-based Biomaterials segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, for medical use primarily in the Ophthalmic, Orthopedic and Veterinary markets. As a result of the sale of Landec Ag to INCOTEC and the termination of the Monsanto Agreement in fiscal year 2012, the Company has eliminated the Technology Licensing segment and combined the remainder of that business into the Corporate segment. As a result of this change, the segment information for fiscal years 2012 and 2011 has been reclassified to conform with the current year classification. Corporate licenses Landec’s patented Intellicoat seed coatings to the farming industry and licenses the Company’s Intelimer polymers for personal care products and other industrial products. The Corporate segment also includes general and administrative expenses, non-Food Products Technology and non HA-based Biomaterials interest income and income tax expenses. Beginning in fiscal year 2013, the Food Products Technology, the Food Export and the Hyaluronan-based Biomaterials segments include charges for corporate services and tax sharing allocated from the Corporate segment. All of the assets of the Company are located within the United States of America.

The Company’s international sales were as follows (in millions):

	May 26, 2013		May 27, 2012		May 29, 2011
Taiwan	$	31.0	$	22.7	$	21.3
Indonesia	$	21.0	$	23.0	$	20.2
Canada	$	27.8	$	20.8	$	18.4
Belgium	$	16.6	$	15.6	$	16.7
Japan	$	10.6	$	11.1	$	8.4
All Other Countries	$	25.8	$	21.3	$	18.8

Operations by segment consisted of the following (in thousands):

Fiscal Year Ended May 26, 2013	Food Products Technology		Food Export		Hyaluronan- based Biomaterials		Corporate			TOTAL
Net sales	$	320,447	$	78,568	$	41,281	$	1,412		$	441,708
International sales	$	27,532	$	78,442	$	26,792	$	—		$	132,766
Gross profit	$	37,077	$	5,274	$	19,102	$	1,307		$	62,760
Net income (loss)	$	20,526	$	1,660	$	6,835	$	(6,434	)	$	22,587
Identifiable assets	$	180,104	$	21,737	$	80,940	$	8,161		$	290,942
Depreciation and amortization	$	4,761	$	4	$	2,379	$	151		$	7,295
Capital expenditures	$	5,598	$	—	$	3,190	$	89		$	8,877
Dividend income	$	1,125	$	—	$	—	$	—		$	1,125
Interest income	$	42	$	—	$	137	$	—		$	179
Interest expense	$	1,707	$	—	$	301	$	—		$	2,008
Income tax expense	$	3,399	$	339	$	1,400	$	4,314		$	9,452

Fiscal Year Ended May 27, 2012
Net sales	$	207,582	$	71,485	$	34,283	$	4,202		$	317,552
International sales	$	20,528	$	71,054	$	22,904	$	—		$	114,486
Gross profit	$	25,237	$	4,900	$	17,994	$	4,007		$	52,138
Net income (loss)	$	17,527	$	2,269	$	7,672	$	(14,772	)	$	12,696
Identifiable assets	$	169,541	$	18,425	$	81,927	$	7,799		$	277,692
Depreciation and amortization	$	3,191	$	7	$	2,242	$	181		$	5,621
Capital expenditures	$	2,498	$	—	$	2,798	$	75		$	5,371
Dividend income	$	1,125	$	—	$	—	$	—		$	1,125
Interest income	$	30	$	—	$	129	$	21		$	180
Interest expense	$	178	$	—	$	751	$	—		$	929
Income tax expense	$	—	$	—	$	—	$	7,185		$	7,185

Fiscal Year Ended May 29, 2011
Net sales	$	175,664	$	61,663	$	32,505	$	6,897		$	276,729
International sales	$	18,580	$	61,214	$	24,024	$	—		$	103,818
Gross profit	$	18,888	$	3,901	$	17,231	$	6,675		$	46,695
Net income (loss)	$	8,200	$	1,617	$	7,278	$	(13,175	)	$	3,920
Identifiable assets	$	88,241	$	16,320	$	83,954	$	17,797		$	206,312
Depreciation and amortization	$	3,174	$	8	$	1,972	$	159		$	5,313
Capital expenditures	$	3,620	$	—	$	2,817	$	247		$	6,684
Dividend income	$	328	$	—	$	—	$	—		$	328
Interest income	$	129	$	—	$	164	$	137		$	430
Interest expense	$	2	$	—	$	818	$	—		$	820
Income tax expense	$	—	$	—	$	—	$	4,181		$	4,181

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 15 - Quarterly Consolidated Financial Information (unaudited)

12 Months Ended

May 26, 2013

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Text Block]

15. Quarterly Consolidated Financial Information (unaudited)

The following is a summary of the unaudited quarterly results of operations for fiscal years 2013, 2012 and 2011 (in thousands, except for per share amounts):

FY 2013	1st Quarter		2^nd Quarter		3rd Quarter		4th Quarter		FY 2013
Revenues	$	102,074	$	114,654	$	117,867	$	107,113	$	441,708
Gross profit	$	13,763	$	18,459	$	17,508	$	13,030	$	62,760
Net income	$	4,366	$	8,913	$	4,789	$	4,519	$	22,587
Net income per basic share	$	0.17	$	0.35	$	0.19	$	0.17	$	0.87
Net income per diluted share	$	0.17	$	0.34	$	0.18	$	0.17	$	0.85

FY 2012	1st Quarter		2^nd Quarter		3rd Quarter		4th Quarter		FY 2012
Revenues	$	73,301	$	81,570	$	80,064	$	82,617	$	317,552
Gross profit	$	11,250	$	13,010	$	13,172	$	14,706	$	52,138
Net income	$	1,812	$	3,340	$	4,765	$	2,779	$	12,696
Net income per basic share	$	0.07	$	0.13	$	0.19	$	0.11	$	0.49
Net income per diluted share	$	0.07	$	0.13	$	0.18	$	0.11	$	0.49

FY 2011	1st Quarter		2^nd Quarter		3rd Quarter		4th Quarter			FY 2011
Revenues	$	64,953	$	70,168	$	73,508	$	68,100		$	276,729
Gross profit	$	11,817	$	11,855	$	12,477	$	10,546		$	46,695
Net income (loss)	$	2,304	$	2,055	$	2,298	$	(2,737	)	$	3,920
Net income (loss) per basic share	$	0.09	$	0.08	$	0.09	$	(0.10	)	$	0.15
Net income (loss) per diluted share	$	0.09	$	0.08	$	0.09	$	(0.10	)	$	0.15

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References + Details

Accounting Policies, by Policy (Policies)

12 Months Ended

May 26, 2013

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

Consolidation, Policy [Policy Text Block]

Basis of Consolidation

Reclassification, Policy [Policy Text Block]

Reclassifications

Certain reclassifications have been made to prior year financial statements to conform to the current year presentation.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentrations of Risk

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of Long-Lived Assets

Financial Instruments Policy [Policy Text Block]

Financial Instruments

Trade and Other Accounts Receivable, Policy [Policy Text Block]

Accounts Receivable and Allowance for Doubtful Accounts

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

Shipping and Handling Cost, Policy [Policy Text Block]

Shipping and Handling Costs

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

Marketable Securities, Policy [Policy Text Block]

Marketable Securities

Inventory, Policy [Policy Text Block]

Inventories

Inventories are stated at the lower of cost (using the first-in, first-out method) or market. As of May 26, 2013 and May 27, 2012 inventories consisted of (in thousands):

	May 26, 2013		May 27, 2012
Finished goods	$	11,297	$	9,406
Raw materials		9,290		9,876
Work in progress		3,526		2,729
Inventories, net	$	24,113	$	22,011

Advertising Costs, Policy [Policy Text Block]

Advertising Expense

Advertising expenditures for the Company are expensed as incurred. Advertising expense for the Company for fiscal years 2013, 2012 and 2011 was $445,000, $406,000 and $458,000, respectively.

Receivables, Policy [Policy Text Block]

Notes and Advances Receivable

Related Party Transactions

All related party transactions are monitored quarterly by the Company and approved by the Audit Committee of the Board of Directors.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

Goodwill and Intangible Assets, Policy [Policy Text Block]

Long-Lived Assets

Investment In Non-Public Companies [Policy Text Block]

Investment in Non-Public Company

Revenue Recognition, Deferred Revenue [Policy Text Block]

Deferred Revenue

Non Controlling Interest [Policy Text Block]

Non-Controlling Interest

Income Tax, Policy [Policy Text Block]

Income Taxes

1. Organization, Basis of Presentation, and Summary of Significant Accounting Policies (continued)

Earnings Per Share, Policy [Policy Text Block]

Per Share Information

The following table sets forth the computation of diluted net income per share (in thousands, except per share amounts):

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Numerator:
Net income applicable to Common Stockholders	$	22,587	$	12,696	$	3,920
Denominator:
Weighted average shares for basic net income per share		25,830		25,849		26,397
Effect of dilutive securities:
Stock options and restricted stock units		796		277		229
Weighted average shares for diluted net income per share		26,626		26,126		26,626

Diluted net income per share	$	0.85	$	0.49	$	0.15

Cost of Sales, Policy [Policy Text Block]

Cost of Sales

Research and Development Expense, Policy [Policy Text Block]

Research and Development Expenses

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Accounting for Stock-Based Compensation

The following table summarizes the stock-based compensation by income statement line item:

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Research and development	$	718,000	$	530,000	$	565,000
Sales, general and administrative		977,000		1,342,000		1,386,000
Total stock-based compensation expense	$	1,695,000	$	1,872,000	$	1,951,000

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Expected life (in years)		3.76		3.76		3.76
Risk-free interest rate		0.48%		0.59%		1.16%
Volatility		0.53		0.53		0.52
Dividend yield		0%		0%		0%

Fair Value Measurement, Policy [Policy Text Block]

Fair Value Measurements

The accounting guidance established a three-tier hierarchy for fair value measurements, which prioritizes the inputs used in measuring fair value as follows:

Level 1 – observable inputs such as quoted prices for identical instruments in active markets.

Level 2 – inputs other than quoted prices in active markets that are observable either directly or indirectly through corroboration with observable market data.

Level 3 – unobservable inputs in which there is little or no market data, which would require the Company to develop its own assumptions.

The fair value of the Company’s interest rate swap is determined based on model inputs that can be observed in a liquid market, including yield curves, and is categorized as a Level 2 measurement.

	At May 26, 2013			At May 27, 2012
Revenue growth rates	3%	to	9%	3%	to	24%
Expense growth rates	3%	to	8%	3%	to	18%
Income tax rates		15%			25%
Discount rates	18%	to	28%	14%	to	21%

	Impact on value of Windset investment as of May 26, 2013
10% increase in revenue growth rates	$1,700
10% increase in expense growth rates	($1,400)
10% increase in income tax rates	($100)
10% increase in discount rates	($900)

The following table summarizes the fair value of the Company’s assets and liabilities that are measured at fair value on a recurring basis, as of May 26, 2013 and May 27, 2012 (in thousands):

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

Intangibles-Goodwill and Other

Presentation of Comprehensive Income

Fair Value Measurement

Disclosures about Offsetting Assets and Liabilities

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Tables)

12 Months Ended

May 26, 2013

Accounting Policies [Abstract]

Allowance for Credit Losses on Financing Receivables [Table Text Block]

	Balance at beginning of period		Additions from acquisitions and additions from charges to costs and expenses		Write offs net of recoveries			Balance at end of period
Year ended May 29, 2011	$	189	$	209	$	(56	)	$	342

Year ended May 27, 2012	$	342	$	248	$	(78	)	$	512

Year ended May 26, 2013	$	512	$	109	$	(38	)	$	583

Schedule of Inventory, Current [Table Text Block]

	May 26, 2013		May 27, 2012
Finished goods	$	11,297	$	9,406
Raw materials		9,290		9,876
Work in progress		3,526		2,729
Inventories, net	$	24,113	$	22,011

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Numerator:
Net income applicable to Common Stockholders	$	22,587	$	12,696	$	3,920
Denominator:
Weighted average shares for basic net income per share		25,830		25,849		26,397
Effect of dilutive securities:
Stock options and restricted stock units		796		277		229
Weighted average shares for diluted net income per share		26,626		26,126		26,626

Diluted net income per share	$	0.85	$	0.49	$	0.15

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Research and development	$	718,000	$	530,000	$	565,000
Sales, general and administrative		977,000		1,342,000		1,386,000
Total stock-based compensation expense	$	1,695,000	$	1,872,000	$	1,951,000

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Fiscal Year Ended May 26, 2013		Fiscal Year Ended May 27, 2012		Fiscal Year Ended May 29, 2011
Expected life (in years)		3.76		3.76		3.76
Risk-free interest rate		0.48%		0.59%		1.16%
Volatility		0.53		0.53		0.52
Dividend yield		0%		0%		0%

Schedule of Effect of Significant Unobservable Inputs for Investement [Table Text Block]

	At May 26, 2013			At May 27, 2012
Revenue growth rates	3%	to	9%	3%	to	24%
Expense growth rates	3%	to	8%	3%	to	18%
Income tax rates		15%			25%
Discount rates	18%	to	28%	14%	to	21%

Schedule of Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets [Table Text Block]

	Impact on value of Windset investment as of May 26, 2013
10% increase in revenue growth rates	$1,700
10% increase in expense growth rates	($1,400)
10% increase in income tax rates	($100)
10% increase in discount rates	($900)

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	Fair Value at May 26, 2013						Fair Value at May 27, 2012
	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3
Assets:
Marketable securities	$	1,545	$	-	$	-	$	-	$	-	$	-
Investment in private company		-		-		29,600		-		-		21,500
Total	$	1,545	$	-	$	29,600	$	-	$	-	$	21,500

Liabilities:
Contingent consideration	$	-	$	-	$	-	$	-	$	-	$	3,933
Interest rate swap		-		163		-		-		347		-
Total	$	-	$	163	$	-	$	-	$	347	$	3,933

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References + Details

Note 2 - Acquisitions (Tables)

12 Months Ended

May 26, 2013

Business Combinations [Abstract]

Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]

Cash	$	62,900
Contingent consideration		3,933
Total	$	66,833

Schedule of Purchase Price Allocation [Table Text Block]

Accounts receivable, net	$	7,057
Inventories, net		1,409
Property and equipment		11,669
Other tangible assets		306
Intangible assets		43,500
Total identifiable assets acquired		63,941
Accounts payable and other liabilities		(8,391	)
Deferred taxes		(1,875	)
Total liabilities assumed		(10,266	)
Net identifiable assets acquired		53,675
Goodwill		13,158
Net assets acquired	$	66,833

Note 6 - Property and Equipment (Tables)

12 Months Ended

May 26, 2013

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

	Years of Useful Life			May 26, 2013			May 27, 2012
Land and building	15	-	30	$	52,527		$	51,993
Leasehold improvements	3	-	20		1,029			1,103
Computer, capitalized software, machinery, equipment and auto	3	-	7		47,066			43,094
Furniture and fixtures	5	-	7		766			551
Construction in process					3,355			727
Gross property and equipment					104,743			97,468
Less accumulated depreciation and amortization					(38,932	)		(33,973	)
Net property and equipment				$	65,811		$	63,495

Note 7 - Intangible Assets (Tables)

12 Months Ended

May 26, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

	Food Products Technology		Corporate			Hyaluronan- based Biomaterials		Total

Balance as of May 30, 2010	$	22,581	$	4,780		$	13,793	$	41,154
Goodwill acquired/reclassified during the period		—		—			88		88
Goodwill impaired during the period		—		(4,780	)		—		(4,780	)
Balance as of May 29, 2011		22,581		—			13,881		36,462
Goodwill acquired during the period		13,158		—			—		13,158
Balance as of May 27, 2012		35,739		—			13,881		49,620
Goodwill acquired during the period		—		—			—		—
Balance as of May 26, 2013	$	35,739	$	—		$	13,881	$	49,620

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	Trademarks & Trade names		Customer Relationships			Total
Balance as of May 30, 2010		12,428		3,674			16,102
Amortization expense		—		(308	)		(308	)
Balance as of May 29, 2011		12,428		3,366			15,794
Acquired during the period		36,000		7,500			43,500
Amortization expense		—		(309	)		(309	)
Balance as of May 27, 2012		48,428		10,557			58,985
Amortization expense		—		(951	)		(951	)
Balance as of May 26, 2013	$	48,428	$	9,606		$	58,034

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References + Details

Note 8 - Stockholders' Equity (Tables)

12 Months Ended

May 26, 2013

Stockholders' Equity Note [Abstract]

Schedule of Share-based Compensation, Activity [Table Text Block]

				Restricted Stock Outstanding					Stock Options Outstanding
	RSUs and Options Available for Grant			Number of Restricted Shares			Weighted Average Grant Date Fair Value		Number of Stock Options			Weighted Average Exercise Price
Balance at May 30, 2010		770,311			431,605		$	6.35		2,456,829		$	6.13
Granted		(129,335	)		32,335		$	6.00		97,000		$	6.00
Awarded/Exercised		—			(48,855	)	$	9.48		(217,076	)	$	3.46
Forfeited		—			—			—		(18,000	)	$	10.63
Balance at May 29, 2011		640,976			415,085		$	5.96		2,318,753		$	6.34
Granted		(191,333	)		47,833		$	6.67		143,500		$	6.67
Awarded/Exercised		—			(111,252	)	$	6.36		(371,727	)	$	5.40
Forfeited		—			(3,500	)	$	5.84		(5,657	)	$	5.76
Plan shares expired		—			—			—		(38,437	)	$	8.23
Balance at May 27, 2012		449,643			348,166		$	5.93		2,046,432		$	6.50
Granted		(26,666	)		6,666		$	9.01		20,000		$	9.01
Awarded/Exercised		—			(231,086	)	$	5.74		(671,563	)	$	6.30
Forfeited		—			(28,416	)	$	6.20		(44,977	)	$	6.34
Plan shares expired		—			—			—		(10,000	)	$	13.32
Balance at May 26, 2013		422,977			95,330		$	6.52		1,339,892		$	6.58

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

			Options Outstanding							Options Exercisable
Range of Exercise Prices			Number of Shares Outstanding	Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Aggregate Intrinsic Value		Number of Shares Exercisable		Weighted Average Exercise Price		Aggregate Intrinsic Value
$5.63	-	$5.63	423,101		4.00	$	5.63	$	3,490,583		423,101	$	5.63	$	3,490,583
$5.65	-	$6.22	367,135		3.57	$	6.15	$	2,836,564		359,005	$	6.16	$	2,772,504
$6.35	-	$7.50	443,656		2.89	$	6.77	$	3,153,362		391,496	$	6.79	$	2,776,788
$8.19	-	$13.32	106,000		2.31	$	11.09	$	296,110		89,332	$	11.47	$	214,937
$5.63	-	$13.32	1,339,892		3.38	$	6.58	$	9,776,619		1,262,934	$	6.55	$	9,254,812

Schedule of Nonvested Share Activity [Table Text Block]

	Stock Options					Restricted Stock
	Shares			Weighted Average Fair Value		Shares			Weighted Average Fair Value
Unvested at May 27, 2012		425,870		$	2.43		348,166		$	5.93
Granted		20,000		$	3.57		6,666		$	9.01
Vested/Awarded		(323,935	)	$	2.87		(231,086	)	$	5.74
Forfeited		(44,977	)	$	—		(28,416	)	$	6.20
Unvested at May 26, 2013		76,958		$	2.29		95,330		$	6.52

Note 9 - Debt (Tables)

12 Months Ended

May 26, 2013

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments [Table Text Block]

	May 26, 2013			May 27, 2012
Real estate loan agreement with General Electric Capital Corporation (“GE Capital”); due in monthly principal and interest payments of $133,060 through May 1, 2022 with interest based on a fixed rate of 4.02% per annum	$	17,065		$	17,957
Real estate bridge loan agreement with GE Capital; due in monthly principal and interest payments of $8,902 with a lump sum final principal payment due on May 1, 2013 with interest based on a fixed rate of 4.02% per annum		—			1,200
Capital equipment loan with GE Capital; due in monthly principal and interest payments of $175,356 through May 1, 2019 with interest based on a fixed rate of 4.39% per annum		11,080			12,660
Term note with BMO Harris; due in monthly payments of $250,000 through May 23, 2016 with interest payable monthly at LIBOR plus 2% per annum		9,000			12,000
Industrial revenue bonds (“IRBs”) issued by Lifecore; due in annual payments through 2020 with interest at a variable rate set weekly by the bond remarketing agent (0.38% and 0.42% at May 26, 2013 and May 27, 2012, respectively)		3,160			3,500
Total		40,305			47,317
Less current portion		(5,933	)		(7,012	)
Long-term portion	$	34,372		$	40,305

Schedule of Maturities of Long-term Debt [Table Text Block]

	GE RE Loan		GE Equipment		BMO Harris		IRB		Total

FY 2014	$	928	$	1,650	$	3,000	$	355	$	5,933

FY 2015		966		1,725		3,000		365		6,056

FY 2016		1,005		1,801		3,000		375		6,181

FY 2017		1,047		1,882		—		390		3,319

FY 2018		1,089		1,967		—		400		3,456

Thereafter		12,030		2,055		—		1,275		15,360

Total	$	17,065	$	11,080	$	9,000	$	3,160	$	40,305

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

Note 11 - Income Taxes (Tables)

12 Months Ended

May 26, 2013

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	Year ended May 26, 2013			Year ended May 27, 2012			Year ended May 29, 2011
Current:
Federal	$	2,808		$	4,597		$	881
State		(18	)		(586	)		176
Foreign		56			56			—
Total		2,846			4,067			1,057
Deferred:
Federal		6,218			2,641			3,140
State		388			477			(16	)
Total		6,606			3,118			3,124
Income tax expense	$	9,452		$	7,185		$	4,181

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	Year Ended May 26, 2013			Year Ended May 27, 2012			Year Ended May 29, 2011
Provision at U.S. statutory rate (1)	$	11,214		$	6,958		$	2,835
State income taxes, net of federal benefit		731			451			213
Goodwill impairment charge		—			—			1,849
Change in valuation allowance		370			1			(7	)
Tax-exempt interest		—			(40	)		(115	)
Tax credit carryforwards		(801	)		(368	)		(637	)
Transaction costs		—			322			—
Domestic manufacturing deduction		(172	)		(208	)		—
Change in value of contingent consideration		(1,450	)		—			—
Other		(440	)		69			43
Total	$	9,452		$	7,185		$	4,181

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	May 26, 2013			May 27, 2012
Deferred tax assets:
Net operating loss carryforwards	$	3,853		$	3,954
Accruals and reserves		1,388			2,191
Stock-based compensation		621			981
Research and AMT credit carryforwards		486			328
Other		450			428
Gross deferred tax assets		6,798			7,882
Valuation allowance		(783	)		(419	)
Net deferred tax assets		6,015			7,463

Deferred tax liabilities:
Basis difference in investment in non-public company		(5,505	)		(2,510	)
Depreciation and amortization		(5,822	)		(5,575	)
Goodwill and other indefinite life intangibles		(17,160	)		(15,339	)
Deferred tax liabilities		(28,487	)		(23,424	)

Net deferred tax liabilities	$	(22,472	)	$	(15,961	)

Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]

	As of
	May 26, 2013		May 27, 2012			May 29, 2011
Unrecognized tax benefits – beginning of the period	$	766	$	760		$	868
Gross increases – tax positions in prior period		103		1			280
Gross decreases – tax positions in prior period		—		(1	)		(310	)
Gross increases – current-period tax positions		129		246			75
Settlements		—		—			—
Lapse of statute of limitations		—		(240	)		(153	)
Unrecognized tax benefits – end of the period	$	998	$	766		$	760

Note 12 - Commitments and Contingencies (Tables)

12 Months Ended

May 26, 2013

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

	Amount
FY2014	$	2,139
FY2015		1,730
FY2016		1,421
FY2017		1,135
FY2018		554
Thereafter		350
	$	7,329

Note 14 - Business Segment Reporting (Tables)

12 Months Ended

May 26, 2013

Segment Reporting [Abstract]

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	May 26, 2013		May 27, 2012		May 29, 2011
Taiwan	$	31.0	$	22.7	$	21.3
Indonesia	$	21.0	$	23.0	$	20.2
Canada	$	27.8	$	20.8	$	18.4
Belgium	$	16.6	$	15.6	$	16.7
Japan	$	10.6	$	11.1	$	8.4
All Other Countries	$	25.8	$	21.3	$	18.8

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Fiscal Year Ended May 26, 2013	Food Products Technology		Food Export		Hyaluronan- based Biomaterials		Corporate			TOTAL
Net sales	$	320,447	$	78,568	$	41,281	$	1,412		$	441,708
International sales	$	27,532	$	78,442	$	26,792	$	—		$	132,766
Gross profit	$	37,077	$	5,274	$	19,102	$	1,307		$	62,760
Net income (loss)	$	20,526	$	1,660	$	6,835	$	(6,434	)	$	22,587
Identifiable assets	$	180,104	$	21,737	$	80,940	$	8,161		$	290,942
Depreciation and amortization	$	4,761	$	4	$	2,379	$	151		$	7,295
Capital expenditures	$	5,598	$	—	$	3,190	$	89		$	8,877
Dividend income	$	1,125	$	—	$	—	$	—		$	1,125
Interest income	$	42	$	—	$	137	$	—		$	179
Interest expense	$	1,707	$	—	$	301	$	—		$	2,008
Income tax expense	$	3,399	$	339	$	1,400	$	4,314		$	9,452

Fiscal Year Ended May 27, 2012
Net sales	$	207,582	$	71,485	$	34,283	$	4,202		$	317,552
International sales	$	20,528	$	71,054	$	22,904	$	—		$	114,486
Gross profit	$	25,237	$	4,900	$	17,994	$	4,007		$	52,138
Net income (loss)	$	17,527	$	2,269	$	7,672	$	(14,772	)	$	12,696
Identifiable assets	$	169,541	$	18,425	$	81,927	$	7,799		$	277,692
Depreciation and amortization	$	3,191	$	7	$	2,242	$	181		$	5,621
Capital expenditures	$	2,498	$	—	$	2,798	$	75		$	5,371
Dividend income	$	1,125	$	—	$	—	$	—		$	1,125
Interest income	$	30	$	—	$	129	$	21		$	180
Interest expense	$	178	$	—	$	751	$	—		$	929
Income tax expense	$	—	$	—	$	—	$	7,185		$	7,185

Fiscal Year Ended May 29, 2011
Net sales	$	175,664	$	61,663	$	32,505	$	6,897		$	276,729
International sales	$	18,580	$	61,214	$	24,024	$	—		$	103,818
Gross profit	$	18,888	$	3,901	$	17,231	$	6,675		$	46,695
Net income (loss)	$	8,200	$	1,617	$	7,278	$	(13,175	)	$	3,920
Identifiable assets	$	88,241	$	16,320	$	83,954	$	17,797		$	206,312
Depreciation and amortization	$	3,174	$	8	$	1,972	$	159		$	5,313
Capital expenditures	$	3,620	$	—	$	2,817	$	247		$	6,684
Dividend income	$	328	$	—	$	—	$	—		$	328
Interest income	$	129	$	—	$	164	$	137		$	430
Interest expense	$	2	$	—	$	818	$	—		$	820
Income tax expense	$	—	$	—	$	—	$	4,181		$	4,181

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details

Note 15 - Quarterly Consolidated Financial Information (unaudited) (Tables)

12 Months Ended

May 26, 2013

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information [Table Text Block]

FY 2013	1st Quarter		2^nd Quarter		3rd Quarter		4th Quarter		FY 2013
Revenues	$	102,074	$	114,654	$	117,867	$	107,113	$	441,708
Gross profit	$	13,763	$	18,459	$	17,508	$	13,030	$	62,760
Net income	$	4,366	$	8,913	$	4,789	$	4,519	$	22,587
Net income per basic share	$	0.17	$	0.35	$	0.19	$	0.17	$	0.87
Net income per diluted share	$	0.17	$	0.34	$	0.18	$	0.17	$	0.85

FY 2012	1st Quarter		2^nd Quarter		3rd Quarter		4th Quarter		FY 2012
Revenues	$	73,301	$	81,570	$	80,064	$	82,617	$	317,552
Gross profit	$	11,250	$	13,010	$	13,172	$	14,706	$	52,138
Net income	$	1,812	$	3,340	$	4,765	$	2,779	$	12,696
Net income per basic share	$	0.07	$	0.13	$	0.19	$	0.11	$	0.49
Net income per diluted share	$	0.07	$	0.13	$	0.18	$	0.11	$	0.49

FY 2011	1st Quarter		2^nd Quarter		3rd Quarter		4th Quarter			FY 2011
Revenues	$	64,953	$	70,168	$	73,508	$	68,100		$	276,729
Gross profit	$	11,817	$	11,855	$	12,477	$	10,546		$	46,695
Net income (loss)	$	2,304	$	2,055	$	2,298	$	(2,737	)	$	3,920
Net income (loss) per basic share	$	0.09	$	0.08	$	0.09	$	(0.10	)	$	0.15
Net income (loss) per diluted share	$	0.09	$	0.08	$	0.09	$	(0.10	)	$	0.15

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details)	12 Months Ended
	May 26, 2013
Buildings and Leasehold Improvements [Member] \| Minimum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Buildings and Leasehold Improvements [Member] \| Maximum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	30 years
Furniture and Fixtures, Computers, Capitalized Software, Capitalized Leases, Machinery, Equipment and Autos [Member] \| Minimum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Furniture and Fixtures, Computers, Capitalized Software, Capitalized Leases, Machinery, Equipment and Autos [Member] \| Maximum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Software Development [Member] \| Minimum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Software Development [Member] \| Maximum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Minimum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Marketable Securities Contractual Maturity	1 year
Finite-Lived Intangible Asset, Useful Life	12 years
Maximum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Marketable Securities Contractual Maturity	2 years
Finite-Lived Intangible Asset, Useful Life	13 years

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Changes in Allowance for Doubtful Accounts - USD ($) $ in Thousands	May 26, 2013	May 27, 2012	May 29, 2011
Beginning of Period [Member]
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for doubtful accounts	$ 512	$ 342	$ 189
End of Period [Member]
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for doubtful accounts	$ 583	$ 512	$ 342

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Components of Inventories - USD ($) $ in Thousands	May 26, 2013	May 27, 2012
Components of Inventories [Abstract]
Finished goods	$ 11,297	$ 9,406
Raw materials	9,290	9,876
Work in progress	3,526	2,729
Inventories, net	$ 24,113	$ 22,011

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Computation of Diluted Net Income Per Share - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Numerator:
Net income applicable to Common Stockholders (in Dollars)	$ 22,587	$ 12,696	$ 3,920
Denominator:
Weighted average shares for basic net income per share	25,830	25,849	26,397
Effect of dilutive securities:
Stock options and restricted stock units	796	277	229
Weighted average shares for diluted net income per share	26,626	26,126	26,626
Diluted net income per share (in Dollars per share)	$ 0.85	$ 0.49	$ 0.15

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 10, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A7
-Appendix A

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 87-21
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28, 29, 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9

+ Details

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References + Details

- Definition

This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e2646-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 40
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Stock-based Compensation by Income Statement Line Item - USD ($)	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Research and Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 718,000	$ 530,000	$ 565,000
Sales, General and Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	977,000	1,342,000	1,386,000
Stock-based compensation expense	$ 1,695,000	$ 1,872,000	$ 1,951,000

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Fair Value of Stock Option, Weighted Average Assumptions Used	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Fair Value of Stock Option, Weighted Average Assumptions Used [Abstract]
Expected life (in years)	3 years 277 days	3 years 277 days	3 years 277 days
Risk-free interest rate	0.48%	0.59%	1.16%
Volatility	0.53%	0.53%	0.52%
Dividend yield	0.00%	0.00%	0.00%

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Significant Unobservable Inputs Used in Discounted Cash Flow Models	12 Months Ended
	May 26, 2013	May 27, 2012
Minimum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Significant Unobservable Inputs Used in Discounted Cash Flow Models [Line Items]
Revenue growth rates	3.00%	3.00%
Expense growth rates	3.00%	3.00%
Discount rates	18.00%	14.00%
Maximum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Significant Unobservable Inputs Used in Discounted Cash Flow Models [Line Items]
Revenue growth rates	9.00%	24.00%
Expense growth rates	8.00%	18.00%
Discount rates	28.00%	21.00%

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Sensitiviy to Changes in Inputs and Assumptions Used in Discounted Cash Flow Models $ in Thousands	May 26, 2013 USD ($)
Sensitiviy to Changes in Inputs and Assumptions Used in Discounted Cash Flow Models [Abstract]
10% increase in revenue growth rates	$ 1,700
10% increase in expense growth rates	(1,400)
10% increase in income tax rates	(100)
10% increase in discount rates	$ (900)

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Fair Value of Assets and Liabilities Measure on Recurring Basis - USD ($) $ in Thousands	May 26, 2013	May 27, 2012	Apr. 23, 2012
Fair Value, Inputs, Level 1 [Member]
Assets:
Marketable securities	$ 1,545
Total	1,545
Fair Value, Inputs, Level 2 [Member]
Liabilities:
Interest rate swap	163	$ 347
Total	163	347
Fair Value, Inputs, Level 3 [Member]
Assets:
Investment in private company	29,600	21,500
Total	$ 29,600	21,500
Liabilities:
Contingent consideration		3,933
Total		$ 3,933
Contingent consideration			$ (3,933)

Note 2 - Acquisitions (Details) $ in Thousands		1 Months Ended	12 Months Ended
Note 2 - Acquisitions (Details) $ in Thousands	May 29, 2012 USD ($)	Apr. 23, 2012 USD ($)	May 26, 2013 USD ($)	May 27, 2012 USD ($)	May 29, 2011 USD ($)	Apr. 30, 2010 USD ($)
Achieving Revenue Target [Member] \| GreenLine [Member]
Note 2 - Acquisitions (Details) [Line Items]
Business Acquisition, Contingent Consideration, Potential Cash Payment		$ 4,000
Exceeding Revenue Target [Member] \| GreenLine [Member]
Note 2 - Acquisitions (Details) [Line Items]
Business Acquisition, Contingent Consideration, Potential Cash Payment		3,000
Revenue Target [Member] \| GreenLine [Member]
Note 2 - Acquisitions (Details) [Line Items]
Revenues		$ 3,000
GreenLine [Member] \| Customer Base [Member]
Note 2 - Acquisitions (Details) [Line Items]
Finite-lived Intangible Assets Acquired			$ 7,500
Finite-Lived Intangible Asset, Useful Life			13 years
GreenLine [Member]
Note 2 - Acquisitions (Details) [Line Items]
Number of Processing Plants		4
Business Acquisition, Cost of Acquired Entity, Cash Paid		$ 62,900
Business Acquisition, Escrow Deposit		4,700
Business Acquisition, Contingent Consideration, Potential Cash Payment		7,000
Business Acquisition, Contingent Consideration, at Fair Value				$ 3,900
Revenue, Net				9,100
Business Acquisition, Cost of Acquired Entity, Purchase Price		66,800
Effective Income Tax Rate, Continuing Operations			40.00%
Number of Intangible Assets Identified			2
Indefinite Lived Intangible Assets Market Value			$ 36,000
Business Acquisition, Purchase Price Allocation, Goodwill Amount			13,200
Business Acquisition, Purchase Price Allocation, Net Deferred Tax Liabilities, Noncurrent			1,900
Business Combination, Acquisition Related Costs				1,400
Lifecore [Member]
Note 2 - Acquisitions (Details) [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid						$ 40,000
Business Acquisition, Contingent Consideration, Potential Cash Payment						$ 10,000
Business Acquisition, Contingent Consideration, Cash Payment	$ 10,000
Business Acquisition, Cost of Acquired Entity, Cash Paid		62,900
Revenues			$ 441,708	$ 317,552	$ 276,729
Business Acquisition, Contingent Consideration, at Fair Value		(3,933)
Business Acquisition, Cost of Acquired Entity, Purchase Price		66,833
Effective Income Tax Rate, Continuing Operations			30.00%	36.00%	52.00%
Finite-lived Intangible Assets Acquired				$ 43,500
Business Acquisition, Purchase Price Allocation, Goodwill Amount		$ 13,158

Note 2 - Acquisitions (Details) - Acquisition Date Fair Value of Total Consideration Transferred $ in Thousands	Apr. 23, 2012 USD ($)
Acquisition Date Fair Value of Total Consideration Transferred [Abstract]
Cash	$ 62,900
Contingent consideration	3,933
Total	$ 66,833

- Definition

Fair value, as of the acquisition date, of potential payments under the contingent consideration arrangement including cash and shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 35
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910684&loc=d3e4570-128470

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 30
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=18499824&loc=d3e4237-128469

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 30
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=18499824&loc=d3e4243-128469

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 40
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910732&loc=d3e4805-128471

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 25
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6946367&loc=d3e3642-128468

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 25
-Paragraph 27
-URI http://asc.fasb.org/extlink&oid=6946367&loc=d3e3629-128468

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(3),(c)(1)
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph g(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 29, 30, 41, 42, 64
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph f
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 65
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 2 - Acquisitions (Details) - Summary of the Estimated Fair Values of GreenLines Assets Acquired and Liabilities Assumed $ in Thousands	Apr. 23, 2012 USD ($)
Summary of the Estimated Fair Values of GreenLines Assets Acquired and Liabilities Assumed [Abstract]
Accounts receivable, net	$ 7,057
Inventories, net	1,409
Property and equipment	11,669
Other tangible assets	306
Intangible assets	43,500
Total identifiable assets acquired	63,941
Accounts payable and other liabilities	(8,391)
Deferred taxes	(1,875)
Total liabilities assumed	(10,266)
Net identifiable assets acquired	53,675
Goodwill	13,158
Net assets acquired	$ 66,833

Note 3 - Sale of Landec Ag (Details)		3 Months Ended
Note 3 - Sale of Landec Ag (Details)	Jun. 24, 2012 USD ($)	Aug. 27, 2012 USD ($)
Landec Ag LLC [Member]
Note 3 - Sale of Landec Ag (Details) [Line Items]
Proceeds from Divestiture of Businesses, Net of Cash Divested	$ 600,000
Gain (Loss) on Sale of Business	400,000
Disposal Group, Deferred Gain on Disposal	$ 300,000
Amortization Period Of Deferred Gain Loss On Divestiture Of Investment	7 years
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal		$ 100,000
Number of Licensing Agreements	2

Note 4 - Investments in Non-public Companies (Details) - USD ($)	1 Months Ended			3 Months Ended	12 Months Ended
	May 31, 2013	Feb. 15, 2011	May 30, 2010	May 29, 2011	May 26, 2013	May 27, 2012	May 29, 2011	Jul. 16, 2010
Preferred Stock [Member] \| Windset [Member]
Note 4 - Investments in Non-public Companies (Details) [Line Items]
Investments in and Advances to Affiliates, Balance, Shares (in Shares)		150,000
Cost Method Investments		$ 15,000,000
Common Stock [Member] \| Windset [Member]
Note 4 - Investments in Non-public Companies (Details) [Line Items]
Investments in and Advances to Affiliates, Balance, Shares (in Shares)		201
Cost Method Investments		$ 201
Aesthetic Sciences [Member]
Note 4 - Investments in Non-public Companies (Details) [Line Items]
Long-term Investments					$ 793,000			$ 1,800,000
Other than Temporary Impairment Losses, Investments			$ 1,000,000
Windset [Member]
Note 4 - Investments in Non-public Companies (Details) [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners		20.10%
Preferred Stock, Dividend Rate, Percentage		7.50%
Investment Income, Dividend				$ 328,000
Change in Market Value Of Investment in Company				$ 662,000	8,100,000	$ 5,800,000
Cost Method Investments					$ 793,000	$ 793,000
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners					20.10%	20.10%
Dividends and Interest Paid	$ 1,100,000
Investment Income, Dividend					$ 1,125,000	$ 1,125,000	$ 328,000

Note 5 - License Agreements (Details) - USD ($)			1 Months Ended		12 Months Ended
Note 5 - License Agreements (Details) - USD ($)	Jun. 24, 2012	Dec. 01, 2006	Jun. 30, 2010	Mar. 31, 2006	May 26, 2013	May 27, 2012	May 29, 2011
First Four Year [Member] \| INCOTEC [Member]
Note 5 - License Agreements (Details) [Line Items]
Royalty Percentage	20.00%
Last Three Years [Member] \| INCOTEC [Member]
Note 5 - License Agreements (Details) [Line Items]
Royalty Percentage	10.00%
Monsanto [Member]
Note 5 - License Agreements (Details) [Line Items]
License Agreement Term		5 years
Termination Fee		$ 4,000,000
Licenses Revenue					$ 0	$ 2,700,000	$ 5,400,000
INCOTEC [Member]
Note 5 - License Agreements (Details) [Line Items]
License Agreement Term	7 years
Air Products [Member]
Note 5 - License Agreements (Details) [Line Items]
License Agreement Profit Percentage				40.00%
Windset [Member] \| Apio [Member]
Note 5 - License Agreements (Details) [Line Items]
Development Fee			$ 100,000
Annual License Fee Percentage			3.00%
Annual Minimum License Fees			$ 150,000
Nitta [Member]
Note 5 - License Agreements (Details) [Line Items]
Research and Development Arrangement, Contract to Perform for Others, Compensation Earned					$ 688,000

Note 6 - Property and Equipment (Details) - USD ($)	12 Months Ended
Note 6 - Property and Equipment (Details) - USD ($)	May 26, 2013	May 27, 2012	May 29, 2011
Property, Plant and Equipment [Member]
Note 6 - Property and Equipment (Details) [Line Items]
Depreciation, Depletion and Amortization	$ 6,300,000	$ 5,300,000	$ 5,000,000
Depreciation, Depletion and Amortization	7,295,000	5,621,000	5,313,000
Capital Leases, Balance Sheet, Assets by Major Class, Net		158,000
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation		0
Capitalized Computer Software, Amortization	160,000	136,000	$ 136,000
Capitalized Computer Software, Net	$ 343,000	$ 468,000

Note 6 - Property and Equipment (Details) - Components of Property and Equipment	12 Months Ended
	May 26, 2013
Land and Building [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	15 years
Land and Building [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	30 years
Leasehold Improvements [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Leasehold Improvements [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	20 years
Computer, Capitalized Software, Machinery, Equipment and Auto [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Computer, Capitalized Software, Machinery, Equipment and Auto [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Furniture and Fixtures [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Furniture and Fixtures [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	7 years

Note 7 - Intangible Assets (Details) - USD ($)	12 Months Ended
Note 7 - Intangible Assets (Details) - USD ($)	May 26, 2013	May 27, 2012
Lifecore [Member] \| Customer Relationships [Member]
Note 7 - Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	12 years
Lifecore [Member]
Note 7 - Intangible Assets (Details) [Line Items]
Finite-Lived Customer Relationships, Gross	$ 3,700,000
GreenLine [Member] \| Customer Relationships [Member]
Note 7 - Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	13 years
GreenLine [Member]
Note 7 - Intangible Assets (Details) [Line Items]
Finite-Lived Customer Relationships, Gross	$ 7,500,000
Trademarks and Tradenames [Member]
Note 7 - Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	872,000
Customer Relationships [Member]
Note 7 - Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	1,600,000	$ 643,000
Goodwill, Impaired, Accumulated Impairment Loss	4,800,000
Finite-Lived Intangible Assets, Amortization Expense, Next Five Years	$ 885,000

Note 7 - Intangible Assets (Details) - Changes in the Carrying Amount of Goodwill - USD ($) $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Food Products Technology [Member]
Goodwill [Line Items]
Balance	$ 35,739	$ 22,581	$ 22,581
Goodwill acquired/reclassified during the period	0	13,158	0
Goodwill impaired during the period			0
Balance	35,739	35,739	22,581
Corporate [Member]
Goodwill [Line Items]
Balance	0	0	4,780
Goodwill acquired/reclassified during the period	0	0	0
Goodwill impaired during the period			(4,780)
Balance	0	0	0
Hyaluronan-based Biomaterials [Member]
Goodwill [Line Items]
Balance	13,881	13,881	13,793
Goodwill acquired/reclassified during the period	0	0	88
Goodwill impaired during the period			0
Balance	13,881	13,881	13,881
Balance	49,620	36,462	41,154
Goodwill acquired/reclassified during the period	0	13,158	88
Goodwill impaired during the period			(4,780)
Balance	$ 49,620	$ 49,620	$ 36,462

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph l
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Loss recognized during the period that results from the write-down of goodwill after comparing the implied fair value of reporting unit goodwill with the carrying amount of that goodwill. Goodwill is assessed at least annually for impairment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 20
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 47
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Note 7 - Intangible Assets (Details) - Other Intangible Assets - USD ($) $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011	May 30, 2010
Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Balance	$ 48,428	$ 48,428	$ 12,428	$ 12,428
Acquired during the period		36,000
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Balance	9,606	10,557	3,366	3,674
Acquired during the period		7,500
Intangible Assets, Amortization expense	(951)	(309)	(308)
Intangible Assets, Balance	58,034	58,985	15,794	$ 16,102
Acquired during the period		43,500
Intangible Assets, Amortization expense	$ (951)	$ (309)	$ (308)

Note 8 - Stockholders' Equity (Details) - Maximum [Member]	May 26, 2013 shares
Stock Options [Member]
Note 8 - Stockholders' Equity (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	500,000
Stock Grants and Stock Units [Member]
Note 8 - Stockholders' Equity (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	250,000
Stock Appreciation Rights (SARs) [Member]
Note 8 - Stockholders' Equity (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	500,000

Note 8 - Stockholders' Equity (Details) - Stock-Based Compensation Activity - $ / shares	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Restricted Stock [Member]
Note 8 - Stockholders' Equity (Details) - Stock-Based Compensation Activity [Line Items]
Balance	348,166	415,085	431,605
Balance (in Dollars per share)	$ 5.93	$ 5.96	$ 6.35
Granted	(6,666)
Granted	6,666	47,833	32,335
Granted (in Dollars per share)	$ 9.01	$ 6.67	$ 6.00
Awarded/Exercised	(231,086)	(111,252)	(48,855)
Awarded/Exercised (in Dollars per share)	$ 5.74	$ 6.36	$ 9.48
Forfeited	(28,416)	(3,500)
Forfeited (in Dollars per share)	$ 6.20	$ 5.84
Balance	95,330	348,166	415,085
Balance (in Dollars per share)	$ 6.52	$ 5.93	$ 5.96
Stock Options [Member]
Note 8 - Stockholders' Equity (Details) - Stock-Based Compensation Activity [Line Items]
Balance	2,046,432	2,318,753	2,456,829
Balance (in Dollars per share)	$ 6.50	$ 6.34	$ 6.13
Granted	20,000	143,500	97,000
Granted (in Dollars per share)	$ 9.01	$ 6.67	$ 6.00
Awarded/Exercised	(671,563)	(371,727)	(217,076)
Awarded/Exercised (in Dollars per share)	$ 6.30	$ 5.40	$ 3.46
Forfeited	(44,977)	(5,657)	(18,000)
Forfeited (in Dollars per share)	$ 6.34	$ 5.76	$ 10.63
Expired	(10,000)	(38,437)
Expired (in Dollars per share)	$ 13.32	$ 8.23
Balance	1,339,892	2,046,432	2,318,753
Balance (in Dollars per share)	$ 6.58	$ 6.50	$ 6.34
Balance	449,643	640,976	770,311
Granted	(26,666)	(191,333)	(129,335)
Balance	422,977	449,643	640,976

Note 8 - Stockholders' Equity (Details) - Summary of Stock Options Outstanding and Exercisable	12 Months Ended
	May 26, 2013 USD ($) $ / shares shares
$5.63 - $5.63 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Limit	$ 5.63
Exercise Price, Upper Limit	$ 5.63
Number of Shares Outstanding (in Shares) \| shares	423,101
Weighted Average Remaining Contractual Life	4 years
Weighted Average Exercise Price	$ 5.63
Aggregate Intrinsic Value (in Dollars) \| $	$ 3,490,583
Number of Shares Exercisable (in Shares) \| shares	423,101
Weighted Average Exercise Price	$ 5.63
Aggregate Intrinsic Value (in Dollars) \| $	$ 3,490,583
$5.65 - $6.22 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Limit	$ 5.65
Exercise Price, Upper Limit	$ 6.22
Number of Shares Outstanding (in Shares) \| shares	367,135
Weighted Average Remaining Contractual Life	3 years 208 days
Weighted Average Exercise Price	$ 6.15
Aggregate Intrinsic Value (in Dollars) \| $	$ 2,836,564
Number of Shares Exercisable (in Shares) \| shares	359,005
Weighted Average Exercise Price	$ 6.16
Aggregate Intrinsic Value (in Dollars) \| $	$ 2,772,504
$6.35 - $7.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Limit	$ 6.35
Exercise Price, Upper Limit	$ 7.50
Number of Shares Outstanding (in Shares) \| shares	443,656
Weighted Average Remaining Contractual Life	2 years 324 days
Weighted Average Exercise Price	$ 6.77
Aggregate Intrinsic Value (in Dollars) \| $	$ 3,153,362
Number of Shares Exercisable (in Shares) \| shares	391,496
Weighted Average Exercise Price	$ 6.79
Aggregate Intrinsic Value (in Dollars) \| $	$ 2,776,788
$8.19 - $13.32 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Limit	$ 8.19
Exercise Price, Upper Limit	$ 13.32
Number of Shares Outstanding (in Shares) \| shares	106,000
Weighted Average Remaining Contractual Life	2 years 113 days
Weighted Average Exercise Price	$ 11.09
Aggregate Intrinsic Value (in Dollars) \| $	$ 296,110
Number of Shares Exercisable (in Shares) \| shares	89,332
Weighted Average Exercise Price	$ 11.47
Aggregate Intrinsic Value (in Dollars) \| $	$ 214,937
$5.63 - $13.32 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price, Lower Limit	$ 5.63
Exercise Price, Upper Limit	$ 13.32
Number of Shares Outstanding (in Shares) \| shares	1,339,892
Weighted Average Remaining Contractual Life	3 years 138 days
Weighted Average Exercise Price	$ 6.58
Aggregate Intrinsic Value (in Dollars) \| $	$ 9,776,619
Number of Shares Exercisable (in Shares) \| shares	1,262,934
Weighted Average Exercise Price	$ 6.55
Aggregate Intrinsic Value (in Dollars) \| $	$ 9,254,812

Note 8 - Stockholders' Equity (Details) - Summary of Activity Relating to Unvested Stock Option Grants and RSUs - $ / shares	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Stock Options [Member]
Note 8 - Stockholders' Equity (Details) - Summary of Activity Relating to Unvested Stock Option Grants and RSUs [Line Items]
Balance	76,958	425,870
Balance (in Dollars per share)	$ 2.29	$ 2.43
Granted	20,000	143,500	97,000
Granted (in Dollars per share)	$ 3.57
Vested/Awarded	(323,935)
Vested/Awarded (in Dollars per share)	$ 2.87
Forfeited	(44,977)
Restricted Stock [Member]
Note 8 - Stockholders' Equity (Details) - Summary of Activity Relating to Unvested Stock Option Grants and RSUs [Line Items]
Balance	95,330	348,166
Balance (in Dollars per share)	$ 6.52	$ 5.93	$ 5.96
Granted	6,666
Granted (in Dollars per share)	$ 9.01	6.67	6.00
Vested/Awarded	(231,086)
Vested/Awarded (in Dollars per share)	$ 5.74
Forfeited	(28,416)
Forfeited (in Dollars per share)	$ 6.20	5.84
Granted (in Dollars per share)	$ 3.57	$ 2.65	$ 2.42
Granted	26,666	191,333	129,335

Note 9 - Debt (Details)	1 Months Ended		3 Months Ended	12 Months Ended
Note 9 - Debt (Details)	May 23, 2012 USD ($)	Apr. 23, 2012 USD ($)	Aug. 26, 2012	May 26, 2013 USD ($)	May 27, 2012 USD ($)	May 29, 2011 USD ($)	Feb. 24, 2013 USD ($)
GE [Member]
Note 9 - Debt (Details) [Line Items]
Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums				$ 1,200,000	$ 1,300,000
Apio [Member]
Note 9 - Debt (Details) [Line Items]
Amortization of Financing Costs				$ 181,000	15,000	$ 0
Minimum Fixed Charge Coverage Ratio				1.10 to 1.0
Lifecore [Member]
Note 9 - Debt (Details) [Line Items]
Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums				$ 149,000	139,000
Amortization of Financing Costs				50,000	161,000	$ 45,000
Minimum Quick Ratio			1) A Credit and Security Agreement (the "Credit Agreement") which includes (a) a one-year, $8.0 million asset-based working capital revolving line of credit, with an interest rate of LIBOR plus 1.85%, with availability based on the combination of Lifecore's eligible accounts receivable and inventory balances (availability was $7.0 million at May 26, 2013) and with no unused fee (at May 26, 2013 and May 27, 2012, no amounts were outstanding under the line of credit) and (b) a $12.0 million term loan which matures in four years due in monthly payments of $250,000 with interest payable monthly based on a variable interest rate of LIBOR plus 2% (the "Term Loan").
Apio [Member]
Note 9 - Debt (Details) [Line Items]
Line of Credit Facility Term		5 years
Line of Credit Facility, Maximum Borrowing Capacity		$ 25,000,000
Debt Instrument, Basis Spread on Variable Rate		2.00%
Line of Credit Facility, Remaining Borrowing Capacity		$ 14,600,000
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage		0.375%
Line of Credit Facility, Amount Outstanding				4,000,000	11,700,000
Lifecore [Member]
Note 9 - Debt (Details) [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 7,000,000
Term Loan [Member]
Note 9 - Debt (Details) [Line Items]
Long-term Debt				$ 12,000,000
Working Capital Line of Credit [Member]
Note 9 - Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 8,000,000
Debt Instrument, Basis Spread on Variable Rate	1.85%
Line of Credit Facility, Remaining Borrowing Capacity							$ 0.00125
Line of Credit Facility, Amount Outstanding							$ 0.0075
Term Loan [Member]
Note 9 - Debt (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	2.00%
Long Term Debt Contractual Maturity Term	4 years
Debt Instrument, Periodic Payment, Principal	$ 250,000
Line of Credit Facility Term	1 year
Number of Financing Agreements	2
Minimum Quick Ratio				1.25 to 1.00
Long-term Debt				$ 40,305,000	$ 47,317,000
Letters of Credit Outstanding, Amount	$ 3,500,000
Minimum Tangible Net Worth				$ 29,000,000

Note 9 - Debt (Details) - Long-term Debt - USD ($) $ in Thousands	May 26, 2013	May 27, 2012
Real Estate Loan [Member]
Debt Instrument [Line Items]
Debt balance	$ 17,065	$ 17,957
Real Estate Bridge Loan [Member]
Debt Instrument [Line Items]
Debt balance		1,200
Capital Equipment Loan [Member]
Debt Instrument [Line Items]
Debt balance	11,080	12,660
Term Note [Member]
Debt Instrument [Line Items]
Debt balance	9,000	12,000
Industrial Revenue Bonds [Member]
Debt Instrument [Line Items]
Debt balance	3,160	3,500
Debt balance	40,305	47,317
Less current portion	(5,933)	(7,012)
Long-term portion	$ 34,372	$ 40,305

Note 9 - Debt (Details) - Long-term Debt (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012
Real Estate Loan [Member]
Debt Instrument [Line Items]
Monthly payment principal and interest (in Dollars)	$ 133,060	$ 133,060
Annual fixed interest rate	4.02%	4.02%
Real Estate Bridge Loan [Member]
Debt Instrument [Line Items]
Monthly payment principal and interest (in Dollars)	$ 8,902	$ 8,902
Annual fixed interest rate	4.02%	4.02%
Capital Equipment Loan [Member]
Debt Instrument [Line Items]
Monthly payment principal and interest (in Dollars)	$ 175,356	$ 175,356
Annual fixed interest rate	4.39%	4.39%
Term Note [Member]
Debt Instrument [Line Items]
Term note with BMO Harris monthly payments (in Dollars)	$ 250,000	$ 250,000
Variable interest rate	2.00%	2.00%
Industrial Revenue Bonds [Member]
Debt Instrument [Line Items]
Variable interest rate	0.38%	0.42%

Note 9 - Debt (Details) - Future Minimum Principal Payments of Debt - USD ($) $ in Thousands	May 26, 2013	May 27, 2012
GE RE Loans [Member]
Note 9 - Debt (Details) - Future Minimum Principal Payments of Debt [Line Items]
FY 2014	$ 928
FY 2015	966
FY 2016	1,005
FY 2017	1,047
FY 2018	1,089
Thereafter	12,030
Total	17,065
GE Equipment [Member]
Note 9 - Debt (Details) - Future Minimum Principal Payments of Debt [Line Items]
FY 2014	1,650
FY 2015	1,725
FY 2016	1,801
FY 2017	1,882
FY 2018	1,967
Thereafter	2,055
Total	11,080
BMO Harris [Member]
Note 9 - Debt (Details) - Future Minimum Principal Payments of Debt [Line Items]
FY 2014	3,000
FY 2015	3,000
FY 2016	3,000
FY 2017	0
FY 2018	0
Thereafter	0
Total	9,000
IRB [Member]
Note 9 - Debt (Details) - Future Minimum Principal Payments of Debt [Line Items]
FY 2014	355
FY 2015	365
FY 2016	375
FY 2017	390
FY 2018	400
Thereafter	1,275
Total	3,160
FY 2014	5,933
FY 2015	6,056
FY 2016	6,181
FY 2017	3,319
FY 2018	3,456
Thereafter	15,360
Total	$ 40,305	$ 47,317

Note 10 - Derivative Financial Instruments (Details) - USD ($)		1 Months Ended
	May 23, 2012	May 30, 2010	May 26, 2013	May 27, 2012
Wells Fargo [Member]
Note 10 - Derivative Financial Instruments (Details) [Line Items]
Interest Rate Swap Term		5 years
Notional Amount of Cash Flow Hedge Instruments		$ 20,000,000
Derivative, Swaption Interest Rate		4.24%
Derivative, Notional Amount		$ 20,000,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 347,000
Derivative Liability, Fair Value, Gross Liability			$ 163,000	$ 347,000

Note 11 - Income Taxes (Details) - USD ($)	12 Months Ended
Note 11 - Income Taxes (Details) - USD ($)	May 26, 2013	May 27, 2012	May 29, 2011	May 30, 2010
Federal [Member]
Note 11 - Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	$ 8,800,000
California [Member]
Note 11 - Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	4,600,000
Other State [Member]
Note 11 - Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	15,200,000
Federal [Member]
Note 11 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Tax Credit Carryforwards, Research	118,000
Deferred Tax Asset Recorded to Additional Paid in Capital	1,200,000
California [Member]
Note 11 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Tax Credit Carryforwards, Research	1,200,000
Deferred Tax Asset Recorded to Additional Paid in Capital	338,000
Federal Therapeutic Drug [Member]
Note 11 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Tax Credit Carryforwards	$ 244,000
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate	35.00%
Increase in Net Income Before Taxes	59.00%	140.00%
Effective Income Tax Rate, Continuing Operations	30.00%	36.00%	52.00%
Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax	$ 874,000
Deferred Tax Assets, Valuation Allowance	783,000	$ 419,000
Valuation Allowance, Deferred Tax Asset, Change in Amount	364,000
Unrecognized Tax Benefits	998,000	$ 766,000	$ 760,000	$ 868,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 807,000

Note 11 - Income Taxes (Details) - Provision for Income Taxes - USD ($) $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Current:
Federal	$ 2,808	$ 4,597	$ 881
State	(18)	(586)	176
Foreign	56	56	0
Total	2,846	4,067	1,057
Deferred:
Federal	6,218	2,641	3,140
State	388	477	(16)
Total	6,511	3,283	3,257
Income tax expense	$ 9,452	$ 7,185	$ 4,181

Note 11 - Income Taxes (Details) - Actual Provision for Income Taxes Differs from Statutory U.S. Federal Income Tax Rate - USD ($)
$ in Thousands

12 Months Ended

May 26, 2013

May 27, 2012

May 29, 2011

Actual Provision for Income Taxes Differs from Statutory U.S. Federal Income Tax Rate [Abstract]

Provision at U.S. statutory rate (1)

^[1]

$ 11,214

$ 6,958

$ 2,835

State income taxes, net of federal benefit

731

451

213

Goodwill impairment charge

1,849

Change in valuation allowance

370

(7)

Tax-exempt interest

(40)

(115)

Tax credit carryforwards

(801)

(368)

(637)

Transaction costs

322

Domestic manufacturing deduction

(172)

(208)

Change in value of contingent consideration

(1,450)

Other

(440)

Total

$ 9,452

$ 7,185

$ 4,181

[1]	Statutory rate was 35% for fiscal years 2013, 2012 and 2011.

Note 11 - Income Taxes (Details) - Significant Components of Deferred Tax Assets and Liabilities - USD ($)	May 26, 2013	May 27, 2012
Deferred tax assets:
Net operating loss carryforwards	$ 3,853,000	$ 3,954,000
Accruals and reserves	1,388,000	2,191,000
Stock-based compensation	621,000	981,000
Research and AMT credit carryforwards	486,000	328,000
Other	450,000	428,000
Gross deferred tax assets	6,798,000	7,882,000
Valuation allowance	(783,000)	(419,000)
Net deferred tax assets	6,015,000	7,463,000
Deferred tax liabilities:
Basis difference in investment in non-public company	(5,505,000)	(2,510,000)
Depreciation and amortization	(5,822,000)	(5,575,000)
Goodwill and other indefinite life intangibles	(17,160,000)	(15,339,000)
Deferred tax liabilities	(28,487,000)	(23,424,000)
Net deferred tax liabilities	$ (22,472,000)	$ (15,961,000)

Note 11 - Income Taxes (Details) - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits - USD ($) $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits [Abstract]
Unrecognized tax benefits – beginning of the period	$ 766	$ 760	$ 868
Gross increases – tax positions in prior period	103	1	280
Gross decreases – tax positions in prior period		(1)	(310)
Gross increases – current-period tax positions	129	246	75
Lapse of statute of limitations		(240)	(153)
Unrecognized tax benefits – end of the period	$ 998	$ 766	$ 760

Note 12 - Commitments and Contingencies (Details) - USD ($)	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Commitments and Contingencies Disclosure [Abstract]
Operating Leases, Rent Expense	$ 4,800,000	$ 1,500,000	$ 1,200,000
Accrued Bonuses	548,000	$ 526,000
Purchase Commitment, Remaining Minimum Amount Committed	2,200,000
Payments on Purchase Commitments	$ 9,500,000

Note 12 - Commitments and Contingencies (Details) - Future Minimum Lease Payments Under Operating Leases, Excluding Land Leases $ in Thousands	May 26, 2013 USD ($)
Future Minimum Lease Payments Under Operating Leases, Excluding Land Leases [Abstract]
FY2014	$ 2,139
FY2015	1,730
FY2016	1,421
FY2017	1,135
FY2018	554
Thereafter	350
	$ 7,329

Note 13 - Employee Savings and Investment Plans (Details)	12 Months Ended
	May 26, 2013
Minimum [Member]
Note 13 - Employee Savings and Investment Plans (Details) [Line Items]
Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent	1.00%
Maximum [Member]
Note 13 - Employee Savings and Investment Plans (Details) [Line Items]
Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent	50.00%

Note 14 - Business Segment Reporting (Details)	12 Months Ended
Note 14 - Business Segment Reporting (Details)	May 26, 2013
Segment Reporting [Abstract]
Number of Operating Segments	3

Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area - USD ($) $ in Thousands	12 Months Ended			36 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011	May 29, 2013
Taiwan [Member]
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]
Segment sales	$ 31,000	$ 22,700		$ 21,300
Indonesia [Member]
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]
Segment sales	21,000	23,000		20,200
Canada [Member]
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]
Segment sales	27,800	20,800		18,400
Belgium [Member]
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]
Segment sales	16,600	15,600		16,700
Japan [Member]
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]
Segment sales	10,600	11,100		8,400
All Other Countries [Member]
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]
Segment sales	25,800	21,300		$ 18,800
Segment sales	$ 441,708	$ 317,552	$ 276,729

Note 14 - Business Segment Reporting (Details) - Operations by Business Segment - USD ($) $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
Food Products Technology [Member]
Segment Reporting Information [Line Items]
Net sales	$ 320,447	$ 207,582	$ 175,664
International sales	27,532	20,528	18,580
Gross profit	37,077	25,237	18,888
Net income (loss)	20,526	17,527	8,200
Identifiable assets	180,104	169,541	88,241
Depreciation and amortization	4,761	3,191	3,174
Capital expenditures	5,598	2,498	3,620
Dividend Income	1,125	1,125	328
Interest income	42	30	129
Interest expense	1,707	178	2
Income tax expense	3,399
Food Export [Member]
Segment Reporting Information [Line Items]
Net sales	78,568	71,485	61,663
International sales	78,442	71,054	61,214
Gross profit	5,274	4,900	3,901
Net income (loss)	1,660	2,269	1,617
Identifiable assets	21,737	18,425	16,320
Depreciation and amortization	4	7	8
Income tax expense	339
HA-based Biomaterials [Member]
Segment Reporting Information [Line Items]
Net sales	41,281	34,283	32,505
International sales	26,792	22,904	24,024
Gross profit	19,102	17,994	17,231
Net income (loss)	6,835	7,672	7,278
Identifiable assets	80,940	81,927	83,954
Depreciation and amortization	2,379	2,242	1,972
Capital expenditures	3,190	2,798	2,817
Interest income	137	129	164
Interest expense	301	751	818
Income tax expense	1,400
Corporate [Member]
Segment Reporting Information [Line Items]
Net sales	1,412	4,202	6,897
Gross profit	1,307	4,007	6,675
Net income (loss)	(6,434)	(14,772)	(13,175)
Identifiable assets	8,161	7,799	17,797
Depreciation and amortization	151	181	159
Capital expenditures	89	75	247
Interest income		21	137
Income tax expense	4,314	7,185	4,181
Total [Member]
Segment Reporting Information [Line Items]
Net sales	441,708	317,552	276,729
International sales	132,766	114,486	103,818
Gross profit	62,760	52,138	46,695
Net income (loss)	22,587	12,696	3,920
Identifiable assets	290,942	277,692	206,312
Depreciation and amortization	7,295	5,621	5,313
Capital expenditures	8,877	5,371	6,684
Dividend Income	1,125	1,125	328
Interest income	179	180	430
Interest expense	2,008	929	820
Income tax expense	9,452	7,185	4,181
Gross profit	62,760	52,138	46,695
Net income (loss)	22,587	12,696	3,920
Identifiable assets	290,942	277,692
Capital expenditures	8,877	5,371	6,684
Dividend Income	1,125	1,125	328
Interest income	179	180	430
Interest expense	2,008	929	820
Income tax expense	$ 9,452	$ 7,185	$ 4,181

Note 15 - Quarterly Consolidated Financial Information (unaudited) (Details) - Summary of Unaudited Quarterly Results of Operations - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	May 26, 2013	May 27, 2012	May 29, 2011
First Quarter [Member]
Note 15 - Quarterly Consolidated Financial Information (unaudited) (Details) - Summary of Unaudited Quarterly Results of Operations [Line Items]
Revenues	$ 102,074	$ 73,301	$ 64,953
Gross profit	13,763	11,250	11,817
Net income	$ 4,366	$ 1,812	$ 2,304
Net income per basic share (in Dollars per share)	$ 0.17	$ 0.07	$ 0.09
Net income per diluted share (in Dollars per share)	$ 0.17	$ 0.07	$ 0.09
Second Quarter [Member]
Note 15 - Quarterly Consolidated Financial Information (unaudited) (Details) - Summary of Unaudited Quarterly Results of Operations [Line Items]
Revenues	$ 114,654	$ 81,570	$ 70,168
Gross profit	18,459	13,010	11,855
Net income	$ 8,913	$ 3,340	$ 2,055
Net income per basic share (in Dollars per share)	$ 0.35	$ 0.13	$ 0.08
Net income per diluted share (in Dollars per share)	$ 0.34	$ 0.13	$ 0.08
Third Quarter [Member]
Note 15 - Quarterly Consolidated Financial Information (unaudited) (Details) - Summary of Unaudited Quarterly Results of Operations [Line Items]
Revenues	$ 117,867	$ 80,064	$ 73,508
Gross profit	17,508	13,172	12,477
Net income	$ 4,789	$ 4,765	$ 2,298
Net income per basic share (in Dollars per share)	$ 0.19	$ 0.19	$ 0.09
Net income per diluted share (in Dollars per share)	$ 0.18	$ 0.18	$ 0.09
Fourth Quarter [Member]
Note 15 - Quarterly Consolidated Financial Information (unaudited) (Details) - Summary of Unaudited Quarterly Results of Operations [Line Items]
Revenues	$ 107,113	$ 82,617	$ 68,100
Gross profit	13,030	14,706	10,546
Net income	$ 4,519	$ 2,779	$ (2,737)
Net income per basic share (in Dollars per share)	$ 0.17	$ 0.11	$ (0.10)
Net income per diluted share (in Dollars per share)	$ 0.17	$ 0.11	$ (0.10)

Label	Element	Value
Shares Paid for Tax Withholding for Share Based Compensation	us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation	145,159
Shares Paid for Tax Withholding for Share Based Compensation	us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation	326,954
Shares Paid for Tax Withholding for Share Based Compensation	us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation	136,374
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	$ 418,000
Issuance of common stock net of taxes paid by Landec on behalf of employees, share price	us-gaap_SharePrice	$ 13.88
Related Party Costs	us-gaap_RelatedPartyCosts	$ 6,700,000
Related Party Costs	us-gaap_RelatedPartyCosts	5,600,000
Related Party Costs	us-gaap_RelatedPartyCosts	$ 3,600,000
MarketableSecuritiesContractualMaturity	lndc_MarketableSecuritiesContractualMaturity	1 year
Income tax rates	lndc_FairValueInputsIncomeTaxRate	15.00%
Income tax rates	lndc_FairValueInputsIncomeTaxRate	25.00%
Certificates of Deposit, at Carrying Value	us-gaap_CertificatesOfDepositAtCarryingValue	$ 701,000
Certificates of Deposit, at Carrying Value	us-gaap_CertificatesOfDepositAtCarryingValue	$ 0
Noncontrolling Interest, Ownership Percentage by Parent	us-gaap_MinorityInterestOwnershipPercentageByParent	60.00%
Stock Repurchased and Retired During Period, Shares	us-gaap_StockRepurchasedAndRetiredDuringPeriodShares	917,244
Stock Repurchased and Retired During Period, Shares	us-gaap_StockRepurchasedAndRetiredDuringPeriodShares	215,684
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	$ 104,743,000
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	97,468,000
Accounts Payable, Related Parties	us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent	786,000
Accounts Payable, Related Parties	us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent	776,000
Allowance for Doubtful Accounts Receivable, Recoveries	us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries	(56,000)
Allowance for Doubtful Accounts Receivable, Recoveries	us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries	(78,000)
Allowance for Doubtful Accounts Receivable, Recoveries	us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries	$ (38,000)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1,262,934
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1,620,562
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	$ 38,932,000
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	$ 33,973,000
DefinedContributionPlanPercenOfEmployeeContributionsMatchedByEmployer	lndc_DefinedContributionPlanPercenOfEmployeeContributionsMatchedByEmployer	67.00%
Allowance for Doubtful Accounts Receivable, Period Increase (Decrease)	us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	$ 209,000
Allowance for Doubtful Accounts Receivable, Period Increase (Decrease)	us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	248,000
Allowance for Doubtful Accounts Receivable, Period Increase (Decrease)	us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	109,000
Stock Repurchased and Retired During Period, Value	us-gaap_StockRepurchasedAndRetiredDuringPeriodValue	5,000,000
Stock Repurchased and Retired During Period, Value	us-gaap_StockRepurchasedAndRetiredDuringPeriodValue	$ 1,200,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	4 years
Preferred Stock, Shares Authorized	us-gaap_PreferredStockSharesAuthorized	2,000,000
Common Stock, Voting Rights	us-gaap_CommonStockVotingRights	one
Common Stock, Capital Shares Reserved for Future Issuance	us-gaap_CommonStockCapitalSharesReservedForFutureIssuance	1,900,000
Cost-method Investments, Realized Losses	us-gaap_CostMethodInvestmentsRealizedLosses	$ 1,000,000
Defined Contribution Plan, Employer Discretionary Contribution Amount	us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount	939,000
Defined Contribution Plan, Employer Discretionary Contribution Amount	us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount	789,000
Defined Contribution Plan, Employer Discretionary Contribution Amount	us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount	720,000
Stock Repurchase Program, Authorized Amount	us-gaap_StockRepurchaseProgramAuthorizedAmount	10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4,100,000
Advertising Expense	us-gaap_AdvertisingExpense	445,000
Advertising Expense	us-gaap_AdvertisingExpense	406,000
Advertising Expense	us-gaap_AdvertisingExpense	$ 458,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	3 years 3 days
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage	us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	25.00%
Deferred Revenue	us-gaap_DeferredRevenue	$ 1,200,000
Deferred Revenue	us-gaap_DeferredRevenue	162,000
Marketable Securities	us-gaap_MarketableSecurities	251,000
Marketable Securities	us-gaap_MarketableSecurities	$ 0
In The Money [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options	us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1,262,934
Director [Member]
Share-based Goods and Nonemployee Services Transaction, Shares Approved for Issuance	us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance	30,000
Beachside [Member]
Services revenue, related party	us-gaap_RevenueFromRelatedParties	$ 2,500,000
Services revenue, related party	us-gaap_RevenueFromRelatedParties	3,800,000
Services revenue, related party	us-gaap_RevenueFromRelatedParties	4,100,000
Accounts Receivable, Related Parties	us-gaap_AccountsReceivableRelatedParties	671,000
Accounts Receivable, Related Parties	us-gaap_AccountsReceivableRelatedParties	323,000
Furniture and Fixtures [Member]
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	766,000
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	551,000
Leasehold Improvements [Member]
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	1,029,000
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	1,103,000
Construction in Progress [Member]
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	3,355,000
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	727,000
Computer Capitalized Software Machinery Equipment And Auto [Member]
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	47,066,000
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	43,094,000
Land and Building [Member]
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	52,527,000
Property, Plant and Equipment, Gross	us-gaap_PropertyPlantAndEquipmentGross	$ 51,993,000
Plan 2005 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	861,038
Number of Shares Outstanding (in Shares)	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	344,300
Non Executive Stock Option Plan 1996 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	4 years
Directors Stock Option Plan 1995 [Member] \| Optionee First Becomes Non Employee Director [Member]
SharesPurchasableWithNonstatutoryStockOption	lndc_SharesPurchasableWithNonstatutoryStockOption	20,000
Directors Stock Option Plan 1995 [Member] \| Served On Board Of Directors For At Least Six Months [Member]
SharesPurchasableWithNonstatutoryStockOption	lndc_SharesPurchasableWithNonstatutoryStockOption	10,000
Windset [Member]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners	20.10%
Short Term [Member]
Marketable Securities	us-gaap_MarketableSecurities	$ 1,300,000
Marketable Securities	us-gaap_MarketableSecurities	0
Noncontrolling Interest [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1,691,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1,671,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1,816,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1,721,000
Proceeds from Noncontrolling Interests	us-gaap_ProceedsFromMinorityShareholders	341,000
Proceeds from Noncontrolling Interests	us-gaap_ProceedsFromMinorityShareholders	403,000
Proceeds from Noncontrolling Interests	us-gaap_ProceedsFromMinorityShareholders	225,000
Payments to Noncontrolling Interests	us-gaap_PaymentsToMinorityShareholders	361,000
Payments to Noncontrolling Interests	us-gaap_PaymentsToMinorityShareholders	258,000
Payments to Noncontrolling Interests	us-gaap_PaymentsToMinorityShareholders	320,000
Additional Paid-in Capital [Member]
Issuance of common stock, net of taxes paid by Landec on behalf of employees	us-gaap_StockIssuedDuringPeriodValueNewIssues	126,000
Issuance of common stock, net of taxes paid by Landec on behalf of employees	us-gaap_StockIssuedDuringPeriodValueNewIssues	61,000
Issuance of common stock, net of taxes paid by Landec on behalf of employees	us-gaap_StockIssuedDuringPeriodValueNewIssues	3,416,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	117,730,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	119,169,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	119,894,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	126,258,000
Taxes paid by Company for stock swaps and RSUs	us-gaap_AdjustmentsToAdditionalPaidInCapitalOther	(218,000)
Taxes paid by Company for stock swaps and RSUs	us-gaap_AdjustmentsToAdditionalPaidInCapitalOther	(260,000)
Taxes paid by Company for stock swaps and RSUs	us-gaap_AdjustmentsToAdditionalPaidInCapitalOther	(49,000)
Treasury Stock, Value, Acquired, Cost Method	us-gaap_TreasuryStockValueAcquiredCostMethod	1,184,000
Treasury Stock, Value, Acquired, Cost Method	us-gaap_TreasuryStockValueAcquiredCostMethod	5,005,000
Stock-based compensation	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1,951,000
Stock-based compensation	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1,872,000
Stock-based compensation	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1,695,000
Tax benefit from stock-based compensation expense	us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	764,000
Tax benefit from stock-based compensation expense	us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	4,057,000
Tax benefit from stock-based compensation expense	us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	1,302,000
Retained Earnings [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13,206,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17,126,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29,822,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	52,409,000
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3,920,000
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12,696,000
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	22,587,000
Common Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	$ 26,000
Shares, Outstanding	us-gaap_SharesOutstanding	26,490,259
Shares, Outstanding	us-gaap_SharesOutstanding	26,405,799
Shares, Outstanding	us-gaap_SharesOutstanding	25,644,580
Shares, Outstanding	us-gaap_SharesOutstanding	26,402,247
Treasury Stock, Value, Acquired, Cost Method	us-gaap_TreasuryStockValueAcquiredCostMethod	$ 1,000
Issuance of common stock , net of taxes paid by Landec on behalf of employees, shares (in Shares)	us-gaap_StockIssuedDuringPeriodSharesNewIssues	91,091
Issuance of common stock , net of taxes paid by Landec on behalf of employees, shares (in Shares)	us-gaap_StockIssuedDuringPeriodSharesNewIssues	72,572
Issuance of common stock , net of taxes paid by Landec on behalf of employees, shares (in Shares)	us-gaap_StockIssuedDuringPeriodSharesNewIssues	597,537
Issuance of common stock for vested restricted stock units (in Shares)	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross	40,133
Issuance of common stock for vested restricted stock units (in Shares)	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross	83,453
Issuance of common stock for vested restricted stock units (in Shares)	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross	160,130
Stock Repurchased During Period, Shares	us-gaap_StockRepurchasedDuringPeriodShares	215,684
Stock Repurchased During Period, Shares	us-gaap_StockRepurchasedDuringPeriodShares	917,244
Accumulated Other Comprehensive Income (Loss) [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	$ (179,000)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	(267,000)
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	(88,000)
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	267,000
Parent [Member]
Issuance of common stock, net of taxes paid by Landec on behalf of employees	us-gaap_StockIssuedDuringPeriodValueNewIssues	126,000
Issuance of common stock, net of taxes paid by Landec on behalf of employees	us-gaap_StockIssuedDuringPeriodValueNewIssues	61,000
Issuance of common stock, net of taxes paid by Landec on behalf of employees	us-gaap_StockIssuedDuringPeriodValueNewIssues	3,416,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	130,784,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	136,055,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	149,742,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	178,693,000
Taxes paid by Company for stock swaps and RSUs	us-gaap_AdjustmentsToAdditionalPaidInCapitalOther	(218,000)
Taxes paid by Company for stock swaps and RSUs	us-gaap_AdjustmentsToAdditionalPaidInCapitalOther	(260,000)
Taxes paid by Company for stock swaps and RSUs	us-gaap_AdjustmentsToAdditionalPaidInCapitalOther	(49,000)
Treasury Stock, Value, Acquired, Cost Method	us-gaap_TreasuryStockValueAcquiredCostMethod	1,184,000
Treasury Stock, Value, Acquired, Cost Method	us-gaap_TreasuryStockValueAcquiredCostMethod	5,006,000
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3,832,000
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12,963,000
Net income and comprehensive loss	us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	22,587,000
Stock-based compensation	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1,951,000
Stock-based compensation	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1,872,000
Stock-based compensation	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1,695,000
Tax benefit from stock-based compensation expense	us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	764,000
Tax benefit from stock-based compensation expense	us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	4,057,000
Tax benefit from stock-based compensation expense	us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	$ 1,302,000
Sales Revenue, Goods, Net [Member] \| Second Top Customer From Food Products Technology Segment [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	11.00%
Sales Revenue, Goods, Net [Member] \| Top Five Customers [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	40.00%
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	45.00%
Sales Revenue, Goods, Net [Member] \| One Of International Customer [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	5.00%
Sales Revenue, Goods, Net [Member] \| Second Top Customer From Food Products Technology Segment [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	13.00%
Sales Revenue, Goods, Net [Member] \| Two Of International Customers Individually [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	5.00%
Sales Revenue, Goods, Net [Member] \| International Customers [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	30.00%
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	36.00%
Sales Revenue, Goods, Net [Member] \| Top Customer From Food Products Technology Segment [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	16.00%
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	17.00%
Accounts Receivable [Member] \| Top Customer From Food Products Technology Segment [Member]
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	15.00%
Concentration Risk, Percentage	us-gaap_ConcentrationRiskPercentage1	11.00%
H Abased Biomaterials [Member]
ProjectedCashFlow	lndc_ProjectedCashFlow	$ 8,400,000
PercentageOfEstimatedFairValueExceedsNetBookValue	lndc_PercentageOfEstimatedFairValueExceedsNetBookValue	117.00%
DifferenceBetweenProjectedCashFlowAndActualCashFlow	lndc_DifferenceBetweenProjectedCashFlowAndActualCashFlow	$ 4,800,000
Goodwill, net	us-gaap_Goodwill	$ 13,900,000
Fair Value Assumptions, Expected Term	us-gaap_FairValueAssumptionsExpectedTerm	5 years
FairValueAssumptionEffectiveTaxRate	lndc_FairValueAssumptionEffectiveTaxRate	37.00%
Cash, Period Increase (Decrease)	us-gaap_CashPeriodIncreaseDecrease	$ 13,200,000
Food Products Technology [Member]
ProjectedCashFlow	lndc_ProjectedCashFlow	$ 10,200,000
PercentageOfEstimatedFairValueExceedsNetBookValue	lndc_PercentageOfEstimatedFairValueExceedsNetBookValue	111.00%
DifferenceBetweenProjectedCashFlowAndActualCashFlow	lndc_DifferenceBetweenProjectedCashFlowAndActualCashFlow	$ 3,400,000
Fair Value Assumptions, Expected Term	us-gaap_FairValueAssumptionsExpectedTerm	5 years
FairValueAssumptionEffectiveTaxRate	lndc_FairValueAssumptionEffectiveTaxRate	37.00%
Cash, Period Increase (Decrease)	us-gaap_CashPeriodIncreaseDecrease	$ 13,600,000
Maximum Contribution For Employer Match [Member]
DefinedContributionPlansEmployeeContributionsEligibleForEmployerMatch	lndc_DefinedContributionPlansEmployeeContributionsEligibleForEmployerMatch	6.00%
Restricted Stock Units (RSUs) [Member]
Stock-based compensation expense	us-gaap_ShareBasedCompensation	$ 907,000
Stock-based compensation expense	us-gaap_ShareBasedCompensation	826,000
Stock-based compensation expense	us-gaap_ShareBasedCompensation	$ 857,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	1 year 255 days
Stock Options [Member]
Stock-based compensation expense	us-gaap_ShareBasedCompensation	$ 788,000
Stock-based compensation expense	us-gaap_ShareBasedCompensation	1,046,000
Stock-based compensation expense	us-gaap_ShareBasedCompensation	$ 1,094,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	2 years
Stock Options [Member]
Weighted Average Exercise Price	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	$ 12.80
Weighted Average Exercise Price	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.72
Weighted Average Exercise Price	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	$ 6.67
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	88,022
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1,855,167
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2,032,867